Przewlekła obturacyjna choroba płuc
Leczenie

Przewlekła obturacyjna choroba płuc (POChP) to postępujące schorzenie charakteryzujące się przewlekłym ograniczeniem przepływu powietrza. Leczenie POChP opiera się na indywidualnym doborze terapii farmakologicznej i niefarmakologicznej, uwzględniając nasilenie objawów, częstość zaostrzeń oraz stan ogólny pacjenta. Podstawą terapii jest całkowite zaprzestanie palenia tytoniu, co istotnie spowalnia progresję choroby i zmniejsza śmiertelność. Farmakoterapia obejmuje stosowanie bronchodylatorów: krótko działających (SABA, SAMA) o czasie działania 4-6 godzin oraz długo działających (LABA, LAMA) utrzymujących efekt przez 12-24 godziny. W umiarkowanej i ciężkiej POChP preferowana jest terapia skojarzona LABA/LAMA, a u pacjentów z ciężką postacią i częstymi zaostrzeniami stosuje się terapię potrójną (LABA + LAMA + ICS). Kortykosteroidy wziewne (ICS) są wskazane u pacjentów z wysokim poziomem eozynofilów (≥300 komórek/μl) i nie są zalecane jako monoterapia ze względu na ryzyko działań niepożądanych, w tym zapalenia płuc. Nowości terapeutyczne to m.in. dupilumab dla pacjentów z eozynofilowym fenotypem oraz ensifentrine – podwójny inhibitor PDE3 i PDE4 o działaniu rozszerzającym oskrzela i przeciwzapalnym.

Podstawowe zasady leczenia przewlekłej obturacyjnej choroby płuc

Przewlekła obturacyjna choroba płuc (POChP) jest postępującą chorobą płuc charakteryzującą się przewlekłym ograniczeniem przepływu powietrza przez drogi oddechowe. Choć POChP jest nieuleczalna, odpowiednie leczenie może spowolnić progresję choroby, złagodzić objawy i poprawić jakość życia pacjentów12. Główne cele leczenia POChP obejmują zmniejszenie objawów, poprawę tolerancji wysiłku, zapobieganie zaostrzeniom oraz spowolnienie postępu choroby3.

Leczenie POChP powinno być dostosowane indywidualnie do pacjenta w zależności od nasilenia objawów, częstości zaostrzeń oraz ogólnego stanu zdrowia45. Kompleksowe podejście terapeutyczne obejmuje zarówno metody farmakologiczne, jak i niefarmakologiczne, a stopień intensywności leczenia zależy od stadium choroby6.

Zaprzestanie palenia jako kluczowy element terapii

Najważniejszym elementem leczenia POChP, szczególnie u pacjentów palących tytoń, jest całkowite zaprzestanie palenia78. Zaprzestanie palenia jest jedyną interwencją, która może istotnie spowolnić tempo pogarszania się funkcji płuc i zmniejszyć śmiertelność9. U pacjentów z łagodną lub umiarkowaną POChP zaprzestanie palenia może poprawić niektóre objawy i opóźnić rozwój innych10. Programy rzucania palenia, terapia zastępcza nikotyny oraz farmakoterapia mogą pomóc pacjentom w skutecznym zaprzestaniu palenia11.

Farmakoterapia POChP

Farmakoterapia jest podstawą leczenia POChP, szczególnie u pacjentów z umiarkowanymi do ciężkich objawów. Leki stosowane w POChP mają na celu przede wszystkim rozszerzenie dróg oddechowych, zmniejszenie stanu zapalnego i poprawę wymiany gazowej12.

Leki rozszerzające oskrzela

Bronchodylatory są podstawą leczenia farmakologicznego POChP13. Działają poprzez rozluźnienie mięśni wokół dróg oddechowych, co ułatwia oddychanie14. Wyróżniamy dwie główne grupy bronchodylatorów:

  • Krótko działające bronchodylatory (SABA, SAMA) – stosowane doraźnie, gdy objawy nasilają się; działają przez 4-6 godzin1516
  • Długo działające bronchodylatory (LABA, LAMA) – stosowane regularnie, raz lub dwa razy dziennie; efekt utrzymuje się przez około 12-24 godzin1718

W przypadku łagodnej POChP i niewielkiej liczby objawów, pacjentom zaleca się krótko działające bronchodylatory stosowane doraźnie. Przy umiarkowanej lub ciężkiej POChP i częstszych objawach, długo działające bronchodylatory są stosowane jako podstawa leczenia1920.

Często stosuje się kombinację różnych typów bronchodylatorów (LABA + LAMA), co może zapewnić lepszy efekt terapeutyczny niż monoterapia2122. Badania wykazały, że terapia skojarzona LABA/LAMA skuteczniej poprawia funkcje płuc i zmniejsza ryzyko zaostrzeń w porównaniu do monoterapii23.

Kortykosteroidy wziewne

Kortykosteroidy wziewne (ICS) zmniejszają stan zapalny w drogach oddechowych i są zalecane dla pacjentów z ciężką POChP lub z częstymi zaostrzeniami, mimo stosowania bronchodylatorów2425. ICS są zazwyczaj stosowane w połączeniu z długo działającymi bronchodylatorami26.

Warto zauważyć, że ICS nie są zalecane jako monoterapia w POChP27. Ponadto, długotrwałe stosowanie ICS wiąże się z ryzykiem działań niepożądanych, w tym zwiększonym ryzykiem zapalenia płuc28. Najnowsze wytyczne sugerują, że liczba eozynofilów we krwi może być markerem predykcyjnym odpowiedzi na leczenie ICS – pacjenci z wysokimi poziomami eozynofilów (≥300 komórek/μl) mogą odnieść większe korzyści z terapii zawierającej ICS29.

Terapia potrójna

Dla pacjentów z ciężką POChP, u których objawy utrzymują się mimo podwójnej terapii LABA/LAMA lub którzy doświadczają częstych zaostrzeń, zalecana jest terapia potrójna łącząca LABA, LAMA i ICS3031. Badania pokazują, że terapia potrójna może być skuteczniejsza w redukcji zaostrzeń i poprawie jakości życia u pacjentów z zaawansowaną POChP32.

Przykładem leku stosowanego w terapii potrójnej jest flutikazon/wilanterol/umeklidinium (Trelegy Ellipta), który łączy wszystkie trzy składniki w jednym inhalatorze, co może uprościć schemat leczenia i poprawić przestrzeganie zaleceń przez pacjenta33.

Inne leki stosowane w POChP

Oprócz głównych grup leków, w leczeniu POChP stosuje się również:

  • Inhibitory fosfodiesterazy-4 (PDE4) – takie jak roflumilast (Daliresp) – zalecane u pacjentów z ciężką POChP i przewlekłym zapaleniem oskrzeli, szczególnie gdy doświadczają częstych zaostrzeń3435
  • Mukolity – leki rozrzedzające wydzielinę, ułatwiające odkrztuszanie i zmniejszające ryzyko zaostrzeń3637
  • Antybiotyki – stosowane w leczeniu zaostrzeń POChP spowodowanych infekcjami bakteryjnymi3839
  • Kortykosteroidy doustne – krótkie cykle (3-5 dni) stosowane w zaostrzeniach POChP w celu zmniejszenia stanu zapalnego4041

Nowsze opcje leczenia obejmują terapie biologiczne, takie jak Dupixent (dupilumab), który został niedawno zatwierdzony jako dodatkowe leczenie podtrzymujące dla dorosłych z niewystarczająco kontrolowaną POChP i wysoką liczbą eozynofilów we krwi4243. W 2024 roku zatwierdzono również nowy lek Ohtuvayre (ensifentrine), który jest selektywnym podwójnym inhibitorem enzymów PDE3 i PDE4, łączącym właściwości rozszerzające oskrzela i przeciwzapalne4445.

Tlenoterapia i nieinwazyjna wentylacja

Tlenoterapia jest zalecana u pacjentów z ciężką POChP i przewlekłą hipoksemią (niskim poziomem tlenu we krwi)46. Długotrwała tlenoterapia (≥15 godzin dziennie) może znacząco poprawić przeżywalność u pacjentów z POChP i ciężką hipoksemią spoczynkową (PaO2 ≤55 mmHg)4748.

Korzyści z tlenoterapii obejmują:

  • Poprawę przeżywalności
  • Zmniejszenie duszności
  • Poprawę funkcji poznawczych
  • Zmniejszenie ryzyka powikłań sercowo-naczyniowych
  • Zwiększenie tolerancji wysiłku4950

Nieinwazyjna wentylacja dodatnim ciśnieniem (NIPPV/NIV) może być stosowana u pacjentów z ciężkimi zaostrzeniami POChP, szczególnie przy ostrej hiperkapnicznej niewydolności oddechowej. NIV zmniejsza potrzebę intubacji, skraca pobyt w szpitalu i zmniejsza śmiertelność u pacjentów z ciężkimi zaostrzeniami5152.

Rehabilitacja płucna

Rehabilitacja płucna to kompleksowy program obejmujący ćwiczenia fizyczne, edukację zdrowotną, strategie oddechowe i wsparcie psychologiczne5354. Jest zalecana dla pacjentów z POChP, szczególnie dla tych z umiarkowaną do ciężkiej postaci choroby55.

Korzyści z rehabilitacji płucnej obejmują:

  • Poprawę tolerancji wysiłku i zmniejszenie duszności56
  • Zmniejszenie liczby hospitalizacji i ponownych przyjęć57
  • Poprawę jakości życia i zdolności do wykonywania codziennych czynności58
  • Zmniejszenie lęku i depresji związanych z chorobą59

Programy rehabilitacji płucnej są prowadzone przez multidyscyplinarny zespół specjalistów, w tym fizjoterapeutów, lekarzy pulmonologów, pielęgniarki i dietetyków60. Standardowy program rehabilitacji trwa zwykle 6-12 tygodni i obejmuje 2-3 sesje tygodniowo61.

Techniki oddechowe i strategie oszczędzania energii

W ramach rehabilitacji płucnej pacjenci uczą się specjalnych technik oddechowych, takich jak oddychanie przeponowe i oddychanie przez zaciśnięte usta, które mogą pomóc w kontrolowaniu duszności62. Strategie oszczędzania energii pomagają pacjentom wykonywać codzienne czynności przy mniejszym wysiłku i duszności63.

Leczenie zaostrzeń POChP

Zaostrzenia POChP charakteryzują się nagłym pogorszeniem objawów oddechowych, wymagającym zmiany w standardowym leczeniu64. Szybkie rozpoznanie i odpowiednie leczenie zaostrzeń jest kluczowe dla zmniejszenia ryzyka hospitalizacji i poprawy długoterminowych wyników leczenia65.

Leczenie zaostrzeń obejmuje:

  • Zwiększenie dawki i częstości stosowania bronchodylatorów – przede wszystkim krótko działających beta-2-mimetyków (SABA) i/lub krótko działających leków antycholinergicznych66
  • Krótki cykl kortykosteroidów systemowych (zazwyczaj doustnie) – zmniejsza stan zapalny, poprawia funkcję płuc i skraca czas powrotu do zdrowia6768
  • Antybiotyki – zalecane, gdy występują objawy wskazujące na infekcję bakteryjną (zwiększona objętość plwociny, ropna plwocina, nasilona duszność)69
  • Tlenoterapia – u pacjentów z hipoksemią, miareczkowana do osiągnięcia saturacji 88-92%70
  • Nieinwazyjna wentylacja – pierwsza linia leczenia u pacjentów z ostrą hiperkapniczną niewydolnością oddechową71

Ważne jest, aby pacjenci z POChP mieli opracowany plan działania w przypadku zaostrzenia, który określa, jakie leki należy przyjmować i kiedy szukać pomocy medycznej72. Wczesne rozpoczęcie leczenia zaostrzenia może skrócić jego czas trwania i zmniejszyć ryzyko hospitalizacji73.

Interwencje chirurgiczne i procedury bronchoskopowe

Dla wybranych pacjentów z zaawansowaną POChP, u których standardowe leczenie farmakologiczne nie przynosi zadowalających efektów, mogą być rozważane opcje chirurgiczne74. Interwencje te są zarezerwowane dla niewielkiej grupy pacjentów spełniających określone kryteria75.

Chirurgiczna redukcja objętości płuc

Chirurgiczna redukcja objętości płuc (LVRS) polega na usunięciu najbardziej zniszczonych części płuc, co pozwala na lepsze rozprężenie pozostałych, zdrowszych obszarów76. LVRS może poprawić funkcję płuc, zmniejszyć duszność i poprawić wydolność wysiłkową u starannie wyselekcjonowanych pacjentów z rozedmą, głównie z dominującym zajęciem górnych płatów płuc77.

Bronchoskopowa redukcja objętości płuc

Bronchoskopowa redukcja objętości płuc (BLVR) to mniej inwazyjna alternatywa dla LVRS. W tej procedurze, za pomocą bronchoskopu, umieszcza się specjalne zastawki w drogach oddechowych, które blokują przepływ powietrza do najbardziej zniszczonych części płuc78. Zastawki działają jednokierunkowo, pozwalając na wydostanie się powietrza uwięzionego w nadmiernie rozdętych częściach płuc, ale uniemożliwiając jego ponowne wejście79.

Badania wykazały, że BLVR może poprawić funkcję płuc, zmniejszyć duszność i poprawić jakość życia u odpowiednio zakwalifikowanych pacjentów z rozedmą80.

Przeszczepienie płuc

Przeszczepienie płuc jest ostateczną opcją dla pacjentów z bardzo zaawansowaną POChP, którzy nie odpowiadają na inne formy leczenia81. Jest to procedura zarezerwowana dla młodszych pacjentów (zwykle poniżej 65 roku życia) bez istotnych chorób współistniejących82.

Przeszczepienie płuc może znacząco poprawić jakość życia i funkcję płuc, ale wiąże się z ryzykiem powikłań i wymaga dożywotniej immunosupresji83.

Nowsze metody i przyszłe kierunki leczenia POChP

Badania nad nowymi metodami leczenia POChP stale się rozwijają. Niektóre obiecujące kierunki obejmują:

Leki biologiczne

Wspomniany wcześniej dupilumab (Dupixent) jest przykładem nowego leku biologicznego zatwierdzonego do leczenia POChP. Działa on poprzez blokowanie określonych ścieżek zapalnych związanych z eozynofilami84. Dupilumab wykazał skuteczność w zmniejszaniu zaostrzeń i poprawie funkcji płuc u pacjentów z POChP i podwyższonym poziomem eozynofilów85.

Inne leki biologiczne, takie jak antagoniści IL-5 (np. mepolizumab), są badane pod kątem ich skuteczności w leczeniu POChP z eozynofilowym fenotypem zapalnym86.

Bronchoplastyka reoplastyczna

Bronchoplastyka reoplastyczna to nowa metoda bronchoskopowa w leczeniu przewlekłego zapalenia oskrzeli. Polega na dostarczaniu kontrolowanej energii cieplnej do dróg oddechowych w celu zmniejszenia nadmiernej produkcji śluzu i poprawy objawów87.

Denerwacja płucna

Denerwacja płucna (TLD) to bronchoskopowa interwencja mająca na celu przerwanie odruchów nerwowych płucnych, co może potencjalnie zmniejszyć częstość zaostrzeń POChP88.

Terapia komórkami macierzystymi

Badania nad terapią komórkami macierzystymi w POChP są w toku. Komórki macierzyste mezenchymalne (MSC) mają potencjał do regeneracji uszkodzonych tkanek płucnych i modulacji odpowiedzi immunologicznej8990.

Kompleksowe podejście do leczenia POChP

Optymalne leczenie POChP wymaga kompleksowego podejścia, które wykracza poza samą farmakoterapię. Ważne elementy obejmują:

Szczepienia ochronne

Pacjenci z POChP powinni otrzymywać regularne szczepienia przeciwko:

  • Grypie – corocznie91
  • Pneumokokom – zgodnie z aktualnymi zaleceniami92
  • COVID-19 – zgodnie z harmonogramem szczepień93
  • RSV (syncytialny wirus oddechowy) – u pacjentów w wieku 60 lat i starszych94

Szczepienia zmniejszają ryzyko infekcji dróg oddechowych, które mogą prowadzić do zaostrzeń POChP95.

Edukacja pacjenta i samozarządzanie chorobą

Edukacja pacjenta jest kluczowym elementem skutecznego leczenia POChP96. Pacjenci powinni być edukowani na temat:

  • Prawidłowej techniki stosowania inhalatorów97
  • Rozpoznawania wczesnych objawów zaostrzenia i odpowiedniego reagowania98
  • Technik oszczędzania energii przy wykonywaniu codziennych czynności99
  • Znaczenia regularnej aktywności fizycznej100
  • Planu działania w przypadku zaostrzenia101

Wsparcie żywieniowe

Właściwe odżywianie jest ważnym elementem leczenia POChP102. Niedożywienie jest częstym problemem u pacjentów z zaawansowaną POChP i wiąże się z gorszym rokowaniem103.

Zalecenia żywieniowe dla pacjentów z POChP obejmują:

  • Utrzymanie prawidłowej masy ciała104
  • Zbilansowaną dietę bogatą w składniki odżywcze105
  • Adekwatną podaż białka dla utrzymania masy mięśniowej106
  • W przypadku niedowagi – zwiększenie podaży kalorii107

Regularne monitorowanie i opieka długoterminowa

Regularne wizyty kontrolne są niezbędne do monitorowania postępu choroby, oceny skuteczności leczenia i dostosowania planu terapeutycznego w razie potrzeby108. Podczas wizyt kontrolnych należy oceniać:

  • Objawy i ich nasilenie109
  • Funkcję płuc (spirometria)110
  • Częstość i nasilenie zaostrzeń111
  • Technikę inhalacji i przestrzeganie zaleceń terapeutycznych112
  • Jakość życia i zdolność do wykonywania codziennych czynności113

Indywidualizacja leczenia POChP

Leczenie POChP powinno być dostosowane do indywidualnych potrzeb pacjenta, uwzględniając nasilenie choroby, fenotyp, choroby współistniejące i preferencje pacjenta114115.

Według najnowszych wytycznych GOLD (Global Initiative for Chronic Obstructive Lung Disease), pacjentów z POChP klasyfikuje się do grup A-D na podstawie nasilenia objawów i ryzyka zaostrzeń, co pomaga w wyborze odpowiedniej terapii początkowej116117.

Istotne jest również uwzględnienie chorób współistniejących, takich jak choroby sercowo-naczyniowe, osteoporoza, depresja czy zespół metaboliczny, które często towarzyszą POChP i mogą wpływać na wybór leczenia118119.

Podsumowanie zasad leczenia POChP

Leczenie POChP jest procesem kompleksowym i długoterminowym, wymagającym współpracy między pacjentem a zespołem medycznym. Chociaż POChP jest nieuleczalna, odpowiednie leczenie może znacząco poprawić jakość życia pacjentów, zmniejszyć częstość zaostrzeń i spowolnić postęp choroby120.

Kluczowe elementy skutecznego leczenia POChP obejmują:

  • Zaprzestanie palenia tytoniu – najważniejsza interwencja u pacjentów palących121
  • Farmakoterapię dostosowaną do nasilenia objawów i ryzyka zaostrzeń122
  • Rehabilitację płucną dla poprawy wydolności wysiłkowej i jakości życia123
  • Tlenoterapię u pacjentów z przewlekłą hipoksemią124
  • Szczepienia ochronne dla zmniejszenia ryzyka infekcji125
  • Edukację pacjenta i plan samozarządzania chorobą126
  • Regularne monitorowanie i dostosowywanie leczenia127

Nowe metody leczenia, w tym leki biologiczne, innowacyjne procedury bronchoskopowe i potencjalne terapie regeneracyjne, dają nadzieję na dalszą poprawę wyników leczenia POChP w przyszłości128.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/
    There’s currently no cure for chronic obstructive pulmonary disease (COPD), but treatment can help slow the progression of the condition and control the symptoms. […] Treatments include: stopping smoking if you have COPD and you smoke, this is the most important thing you can do; inhalers and tablets to help make breathing easier; pulmonary rehabilitation a specialised programme of exercise and education; surgery or a lung transplant although this is only an option for a very small number of people. […] If COPD is affecting your breathing, you’ll usually be given an inhaler. This is a device that delivers medicine directly into your lungs as you breathe in. […] For most people with COPD, short-acting bronchodilator inhalers are the first treatment used. […] If you experience symptoms regularly or have flare-ups (exacerbations) despite using short-acting bronchodilators, a long-acting bronchodilator inhaler may be recommended.
  • #2 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Treatment is based on how severe your symptoms are and whether you often have bouts when symptoms get worse. These bouts are called exacerbations. Effective therapy can control symptoms, slow how fast the condition worsens, lower the risk of complications and improve your ability to lead an active life. […] The most essential step in any treatment plan for COPD is to quit all smoking. Stopping smoking can keep COPD from getting worse and making it harder to breathe. […] Several kinds of medicines are used to treat the symptoms and complications of COPD. You may take some medicines on a regular basis and others as needed. […] Most medicines for COPD are given using an inhaler. This small hand-held device delivers the medicine straight to your lungs when you breathe in the fine mist or powder.
  • #3 Treating COPD | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treating
    COPD treatment may improve symptoms, reduce the risk of COPD exacerbations and allow you to do more of the activities you enjoy. […] Each person’s COPD symptoms and treatment options are different. You and your healthcare team will work together to create a treatment plan that works for you. Your treatment plan will help you control your symptoms and know what to do when your COPD gets worse. […] There is no cure for COPD, but treatment options may help you: Better control symptoms, Slow the progression of the disease, Reduce the risk of exacerbations or flare ups, Improve your ability to stay active. […] Quitting smoking is an important part of your COPD treatment plan. […] Medication is often one of the first treatment options prescribed by your healthcare provider. […] A pulmonary rehabilitation program offers classes in a small group setting.
  • #4 COPD – Treatment | NHLBI, NIH
    https://www.nhlbi.nih.gov/health/copd/treatment
    If you are diagnosed with COPD, your healthcare provider will determine your treatment plan based on your symptoms and whether you have mild or severe COPD. […] Medicines to treat COPD symptoms include bronchodilators and steroids or nonsteroid medicines that reduce inflammation. A new add-on medicine approved in 2024 may help to control your disease. Your healthcare provider may prescribe an inhaler for you to always carry. Inhalers allow the medicine to go straight to your lungs. […] If your COPD is mild and you dont have symptoms often, your provider may prescribe a short-acting bronchodilator that you take only when you have symptoms. Bronchodilators relax the muscles around your airways, opening them up to help make breathing easier. Short-acting bronchodilators last about 4 to 6 hours.
  • #5 Chronic Obstructive Pulmonary Disease (COPD) Treatment & Management: Approach Considerations, Smoking Cessation, Management of Inflammation
    https://emedicine.medscape.com/article/297664-treatment
    The goal of COPD management is to improve a patients functional status and quality of life by preserving optimal lung function, improving symptoms, and preventing the recurrence of exacerbations. Currently, no treatments aside from lung transplantation have been shown to significantly improve lung function or decrease mortality; however, oxygen therapy (when appropriate) and smoking cessation may reduce mortality. […] Oral and inhaled medications are used for patients with stable disease to reduce dyspnea and improve exercise tolerance. Most of the medications used are directed at the following 4 potentially reversible causes of airflow limitation in a disease state that has largely fixed obstruction: Bronchial smooth muscle contraction, Bronchial mucosal congestion and edema, Airway inflammation, Increased airway secretions.
  • #6 Chronic Obstructive Pulmonary Disease (COPD): Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/807143-treatment
    Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Tobacco smoking accounts for over 70% of COPD cases in high-income countries. In low- and middle-income countries, tobacco smoking accounts for only 30-40% of COPD cases, and household air pollution is a major risk factor. […] Smoking cessation continues to be the most important therapeutic intervention for COPD. Risk factor reduction (eg, influenza vaccine) is appropriate for all stages of COPD. Approaches to management by stage include the following: Stage I (mild obstruction): Short-acting bronchodilator as needed; Stage II (moderate obstruction): Short-acting bronchodilator as needed; long-acting bronchodilator(s); cardiopulmonary rehabilitation; Stage III (severe obstruction): Short-acting bronchodilator as needed; long-acting bronchodilator(s); cardiopulmonary rehabilitation; inhaled glucocorticoids if repeated exacerbations; Stage IV (very severe obstruction or moderate obstruction with evidence of chronic respiratory failure): Short-acting bronchodilator as needed; long-acting bronchodilator(s); cardiopulmonary rehabilitation; inhaled glucocorticoids if repeated exacerbation; long-term oxygen therapy (if criteria met); consider surgical options such as lung volume reduction surgery (LVRS) and lung transplantation. […] Oral and inhaled medications are used for patients with stable COPD to reduce dyspnea, improve exercise tolerance, and prevent complications. Most of the medications used in COPD treatment are directed at the potentially reversible mechanisms of airflow limitation.
  • #7
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/
    There’s currently no cure for chronic obstructive pulmonary disease (COPD), but treatment can help slow the progression of the condition and control the symptoms. […] Treatments include: stopping smoking if you have COPD and you smoke, this is the most important thing you can do; inhalers and tablets to help make breathing easier; pulmonary rehabilitation a specialised programme of exercise and education; surgery or a lung transplant although this is only an option for a very small number of people. […] If COPD is affecting your breathing, you’ll usually be given an inhaler. This is a device that delivers medicine directly into your lungs as you breathe in. […] For most people with COPD, short-acting bronchodilator inhalers are the first treatment used. […] If you experience symptoms regularly or have flare-ups (exacerbations) despite using short-acting bronchodilators, a long-acting bronchodilator inhaler may be recommended.
  • #8 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Treatment is based on how severe your symptoms are and whether you often have bouts when symptoms get worse. These bouts are called exacerbations. Effective therapy can control symptoms, slow how fast the condition worsens, lower the risk of complications and improve your ability to lead an active life. […] The most essential step in any treatment plan for COPD is to quit all smoking. Stopping smoking can keep COPD from getting worse and making it harder to breathe. […] Several kinds of medicines are used to treat the symptoms and complications of COPD. You may take some medicines on a regular basis and others as needed. […] Most medicines for COPD are given using an inhaler. This small hand-held device delivers the medicine straight to your lungs when you breathe in the fine mist or powder.
  • #9 Chronic obstructive pulmonary disease – Wikipedia
    https://en.wikipedia.org/wiki/Chronic_obstructive_pulmonary_disease
    Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. While COPD is incurable, it is preventable and treatable. […] COPD treatments include smoking cessation, vaccinations, pulmonary rehabilitation, inhaled bronchodilators and corticosteroids. Some people may benefit from long-term oxygen therapy, lung volume reduction and lung transplantation. […] The major goals of management are to reduce exposure to risk factors including offering non-pharmacological treatments such as help with stopping smoking. Stopping smoking can reduce the rate of lung function decline and also reduce mortality from smoking-related diseases such as lung cancer and cardiovascular disease. […] A number of medical treatments are used in the management of stable COPD and exacerbations. These include bronchodilators, corticosteroids and antibiotics.
  • #10 Chronic Obstructive Pulmonary Disease (COPD) | Cedars-Sinai
    https://www.cedars-sinai.org/health-library/diseases-and-conditions/c/chronic-obstructive-pulmonary-disease-copd.html
    COPD can be managed with treatment and treatment should be started early on to ensure the best quality of life possible. […] There is no cure for COPD. Current treatments focus on managing symptoms or underlying conditions and improving the patients quality of life. Treatment approaches, including lifestyle changes, medication, rehabilitation and therapy, as well as surgery, vary depending on how severe the COPD is and what has caused it. […] Patients with COPD may need to make lifestyle changes once they have been diagnosed with the condition. The single most important lifestyle change a patient can make is to stop smoking. This is extremely important for patients who have mild or moderate COPD. It can improve some symptoms of COPD and delay others. […] Medications may be prescribed to improve airflow, reduce inflammation and muscle spasms inside the lungs, and cut or thin down mucus and fluid buildup. Antibiotics may be helpful in taking care of infections that may contribute to COPD. Staying current on flu and pneumonia shots can reduce the chances of infection that can cause COPD symptoms to become worse.
  • #11 How COPD Is Treated
    https://www.verywellhealth.com/copd-treatment-915040
    Chronic obstructive pulmonary disease (COPD), an irreversible form of lung disease, is treated with prescription drugs, lifestyle changes, rehabilitation therapies, and surgery in certain cases. […] The right treatment plan can help you control your COPD symptoms and avoid exacerbations (flareups). These include shortness of breath, wheezing, cough, chest tightness, and excess mucus production. […] Every treatment plan should start with healthy lifestyle changes. Medications alone should not be the sole focus of treatment. […] Kicking the cigarette habit is the most important step you can take to manage COPD. Smoking is the leading cause of COPD and will invariably make COPD symptoms worse if you continue. […] Treatment options include nicotine replacement therapy, including aids such as nicotine gum, inhalers, tablets, patches, or nasal sprays.
  • #12 Chronic Obstructive Pulmonary Disease (COPD) Treatment & Management: Approach Considerations, Smoking Cessation, Management of Inflammation
    https://emedicine.medscape.com/article/297664-treatment
    The goal of COPD management is to improve a patients functional status and quality of life by preserving optimal lung function, improving symptoms, and preventing the recurrence of exacerbations. Currently, no treatments aside from lung transplantation have been shown to significantly improve lung function or decrease mortality; however, oxygen therapy (when appropriate) and smoking cessation may reduce mortality. […] Oral and inhaled medications are used for patients with stable disease to reduce dyspnea and improve exercise tolerance. Most of the medications used are directed at the following 4 potentially reversible causes of airflow limitation in a disease state that has largely fixed obstruction: Bronchial smooth muscle contraction, Bronchial mucosal congestion and edema, Airway inflammation, Increased airway secretions.
  • #13 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Bronchodilators are medicines that usually come in inhalers. Bronchodilators relax the muscles around the airways. This can help relieve coughing and make breathing easier. […] Inhaled corticosteroids, often simply called steroids, can lessen airway inflammation and help prevent bouts when COPD symptoms get worse. […] For times when COPD symptoms get worse, short courses of oral corticosteroids for example, 3 to 5 days may prevent more worsening of COPD. […] A medicine approved for severe COPD and symptoms of chronic bronchitis is roflumilast (Daliresp), a phosphodiesterase-4 inhibitor. This medicine lessens airway inflammation and relaxes the airways. […] Oxygen therapy, a pulmonary rehabilitation program and in-home noninvasive ventilation therapy can all help treat COPD. […] These programs usually combine health education, exercise training, breathing techniques, nutrition advice and counseling.
  • #14 COPD – Treatment | NHLBI, NIH
    https://www.nhlbi.nih.gov/health/copd/treatment
    If you are diagnosed with COPD, your healthcare provider will determine your treatment plan based on your symptoms and whether you have mild or severe COPD. […] Medicines to treat COPD symptoms include bronchodilators and steroids or nonsteroid medicines that reduce inflammation. A new add-on medicine approved in 2024 may help to control your disease. Your healthcare provider may prescribe an inhaler for you to always carry. Inhalers allow the medicine to go straight to your lungs. […] If your COPD is mild and you dont have symptoms often, your provider may prescribe a short-acting bronchodilator that you take only when you have symptoms. Bronchodilators relax the muscles around your airways, opening them up to help make breathing easier. Short-acting bronchodilators last about 4 to 6 hours.
  • #15 COPD – Treatment | NHLBI, NIH
    https://www.nhlbi.nih.gov/health/copd/treatment
    If you are diagnosed with COPD, your healthcare provider will determine your treatment plan based on your symptoms and whether you have mild or severe COPD. […] Medicines to treat COPD symptoms include bronchodilators and steroids or nonsteroid medicines that reduce inflammation. A new add-on medicine approved in 2024 may help to control your disease. Your healthcare provider may prescribe an inhaler for you to always carry. Inhalers allow the medicine to go straight to your lungs. […] If your COPD is mild and you dont have symptoms often, your provider may prescribe a short-acting bronchodilator that you take only when you have symptoms. Bronchodilators relax the muscles around your airways, opening them up to help make breathing easier. Short-acting bronchodilators last about 4 to 6 hours.
  • #16
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/
    There’s currently no cure for chronic obstructive pulmonary disease (COPD), but treatment can help slow the progression of the condition and control the symptoms. […] Treatments include: stopping smoking if you have COPD and you smoke, this is the most important thing you can do; inhalers and tablets to help make breathing easier; pulmonary rehabilitation a specialised programme of exercise and education; surgery or a lung transplant although this is only an option for a very small number of people. […] If COPD is affecting your breathing, you’ll usually be given an inhaler. This is a device that delivers medicine directly into your lungs as you breathe in. […] For most people with COPD, short-acting bronchodilator inhalers are the first treatment used. […] If you experience symptoms regularly or have flare-ups (exacerbations) despite using short-acting bronchodilators, a long-acting bronchodilator inhaler may be recommended.
  • #17 COPD – Treatment | NHLBI, NIH
    https://www.nhlbi.nih.gov/health/copd/treatment
    If your COPD is moderate or severe, you may need long-acting bronchodilators that last about 12 hours or more or an anti-inflammatory. You take these every day. A new medication approved in 2024 combines a bronchodilator with a medicine that reduces inflammation (nonsteroid). The medication also helps the body clear mucus. […] If your COPD is severe or your symptoms flare up often, your provider may prescribe a combination of bronchodilators along with an inhaled steroid. Steroids help reduce the inflammation or swelling in your airways that makes it hard to breathe. If a combination of inhaled medicines does not help, an add-on medication, which is used in people with asthma and was approved in 2024 for COPD, may improve your breathing. Antibiotics may be used to treat flare-ups caused by an infection. Be sure to discuss a plan with your provider for treating a flare-up, including any special medicine you might need.
  • #18 Treatment of Stable COPD – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/treatment-of-stable-copd
    Chronic obstructive pulmonary disease (COPD) management involves treatment of chronic stable COPD and treatment of exacerbations. […] Treatment of chronic stable COPD aims to prevent exacerbations and improve lung and physical function through smoking cessation, medication therapy, oxygen therapy, enhancement of nutrition, and pulmonary rehabilitation, including exercise. […] Surgical treatment of COPD is indicated for selected patients. This may include lung volume reduction procedures or lung transplantation. […] Recommended medication therapy is summarized in the table Pharmacotherapy of COPD. […] Inhaled bronchodilators are the mainstay of COPD management; medications include beta-agonists and anticholinergics (antimuscarinics). […] Patients with moderate to severe COPD should be taking medications from one or both of these classes regularly to improve pulmonary function and increase exercise capacity.
  • #19
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/
    There’s currently no cure for chronic obstructive pulmonary disease (COPD), but treatment can help slow the progression of the condition and control the symptoms. […] Treatments include: stopping smoking if you have COPD and you smoke, this is the most important thing you can do; inhalers and tablets to help make breathing easier; pulmonary rehabilitation a specialised programme of exercise and education; surgery or a lung transplant although this is only an option for a very small number of people. […] If COPD is affecting your breathing, you’ll usually be given an inhaler. This is a device that delivers medicine directly into your lungs as you breathe in. […] For most people with COPD, short-acting bronchodilator inhalers are the first treatment used. […] If you experience symptoms regularly or have flare-ups (exacerbations) despite using short-acting bronchodilators, a long-acting bronchodilator inhaler may be recommended.
  • #20 Chronic obstructive pulmonary disease (COPD) – Management Approach | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/7/management-approach
    Ongoing monitoring and assessment in COPD ensures that the goals of treatment are being met. Quality of life and patients’ sense of wellbeing will improve, and hospital admissions will be significantly decreased, when self- or professional monitoring of disease is being utilized. […] One Cochrane review found that integrated disease management (IDM), in which several healthcare providers (physical therapist, pulmonologist, nurse, etc.) work together with patients, probably results in improvement in disease-specific quality of life, exercise capacity, hospital admissions, and hospital days per person. […] The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend that initial treatment is determined by the patients GOLD group at diagnosis. […] Rescue short-acting bronchodilators should be prescribed to all patients for immediate symptom relief.
  • #21 Chronic Obstructive Pulmonary Disease (COPD) Treatment & Management: Approach Considerations, Smoking Cessation, Management of Inflammation
    https://emedicine.medscape.com/article/297664-treatment
    Bronchodilators are the backbone of any COPD treatment regimen. They work by dilating airways, thereby decreasing airflow resistance. This increases airflow and decreases dynamic hyperinflation. Lack of response in pulmonary function testing should not preclude their use. These drugs provide symptomatic relief but do not alter disease progression or decrease mortality. […] The initial choice of agent remains in debate. Historically, beta2 agonists were considered first line and anticholinergics were added as adjuncts. Not surprisingly, studies have shown combination therapy results in greater bronchodilator response and provides greater relief. Monotherapy with either agent and combination therapy with both are acceptable options. […] The use of newly prescribed inhaled long-acting beta-agonist and long-acting anticholinergic drugs for COPD was associated with a 31% increased risk of experiencing a cardiovascular event in a recent nested case-control analysis of a retrospective cohort study.
  • #22 Managing Your COPD Medications | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treating/copd-medications
    Long-acting medicine reduces the swelling and inflammation in your airways and prevents symptoms. These medications need to be taken every day, even when you feel well. […] The following types of medicines are prescribed to treat COPD. It is important to follow your healthcare providers advice about your treatment. Biologic treatment was recently approved as another treatment option for some people living with COPD. […] Biologics are medicines that target the inflammatory disease pathway associated with asthma and COPD. They decrease the inflammation process to help improve lung function. […] Bronchodilators relax the muscles around the airways or breathing tubes which work to help open the airways. When the airways are more open, it helps you breathe easier. […] In many patients with COPD your healthcare provider may recommend combination therapy. Combination therapy includes two different medications in one inhaler or nebulizer treatment. Combination medications can be more effective and also can simplify your medication regimen.
  • #23 GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and | COPD
    https://www.dovepress.com/gold-in-practice-chronic-obstructive-pulmonary-disease-treatment-and-m-peer-reviewed-fulltext-article-COPD
    Bronchodilators—the first-choice pharmacotherapy for COPD across all patient groups—increase airway diameter and decrease air trapping, thereby improving airflow and reducing dyspnea. […] For patients with persistent breathlessness or exercise limitation despite long-acting bronchodilator monotherapy, step-up to a LAMA+LABA is recommended. […] Pharmacological therapy for COPD should be complemented with nonpharmacological approaches, including behavioral therapies and pulmonary rehabilitation, as appropriate. […] Chronic disease management involves regular evaluation to monitor disease progression and treatment response. […] Ensuring continuity of care over time is central to chronic disease management programs, including those for COPD. […] COPD is a leading cause of morbidity and mortality in the United States. Because most patients with COPD are managed in the primary care setting, primary care clinicians play a pivotal role in appropriately managing COPD.
  • #24
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/
    If you’re still becoming breathless when using a long-acting inhaler, or you have frequent flare-ups (exacerbations), a GP may suggest including a steroid inhaler as part of your treatment. […] If your symptoms are not controlled with inhalers, a doctor may recommend taking tablets or capsules as well. […] If you have a particularly bad flare-up, you may be prescribed a short course of steroid tablets to reduce the inflammation in your airways. […] Pulmonary rehabilitation is a specialised programme of exercise and education designed to help people with lung problems such as COPD. […] Nebulised medicine may be used in severe cases of COPD if inhalers have not worked. […] Roflumilast is a new medicine that can be used to treat flare-ups. […] If COPD causes a low level of oxygen in your blood, you may be advised to have oxygen at home through nasal tubes or a mask. […] Surgery is usually only suitable for a small number of people with severe COPD whose symptoms are not controlled with medicine.
  • #25 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Bronchodilators are medicines that usually come in inhalers. Bronchodilators relax the muscles around the airways. This can help relieve coughing and make breathing easier. […] Inhaled corticosteroids, often simply called steroids, can lessen airway inflammation and help prevent bouts when COPD symptoms get worse. […] For times when COPD symptoms get worse, short courses of oral corticosteroids for example, 3 to 5 days may prevent more worsening of COPD. […] A medicine approved for severe COPD and symptoms of chronic bronchitis is roflumilast (Daliresp), a phosphodiesterase-4 inhibitor. This medicine lessens airway inflammation and relaxes the airways. […] Oxygen therapy, a pulmonary rehabilitation program and in-home noninvasive ventilation therapy can all help treat COPD. […] These programs usually combine health education, exercise training, breathing techniques, nutrition advice and counseling.
  • #26 Chronic obstructive pulmonary disease (COPD) – Management Approach | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/7/management-approach
    The effect of treatment regimens containing ICS is higher in patients at higher risk of exacerbations. […] Blood eosinophil count may predict the effectiveness of adding ICS to regular long-acting bronchodilator treatment to prevent exacerbations. […] The European Respiratory Society has produced a guideline on the withdrawal of inhaled corticosteroids in COPD. […] Long-term use of oral corticosteroids in COPD is not recommended. […] A combination preparation of a long-acting bronchodilator and an ICS may be used for patients who require both these agents. […] Multiple studies support triple therapy with LABA/LAMA/ICS as being superior to single- or double-agent therapy with LABA/LAMA or LABA/ICS regarding rate of moderate to severe COPD exacerbations and rate of hospitalization.
  • #27 Treatment of Stable COPD – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/treatment-of-stable-copd
    The frequency of exacerbations can be reduced with the use of anticholinergics, inhaled corticosteroids, or long-acting beta-agonists. […] For home treatment of chronic stable disease, medication administration by metered-dose inhaler or dry-powder inhaler is preferred over administration by nebulizer. […] Inhaled corticosteroids seem to reduce airway inflammation, reverse beta-receptor down-regulation, and inhibit leukotriene and cytokine production. […] They are indicated for patients who have repeated exacerbations or symptoms despite optimal bronchodilator therapy. […] Long-term oxygen therapy prolongs life in patients with COPD whose partial pressure of arterial oxygen (PaO2) is chronically 55 mm Hg. […] Oxygen therapy does the following: brings hematocrit toward normal levels, improves neuropsychologic factors, ameliorates pulmonary hemodynamic abnormalities, and increases exercise tolerance in some patients.
  • #28 Chronic Obstructive Pulmonary Disease (COPD): Diagnosis and Management – Province of British Columbia
    https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/copd
    Non-pharmacological therapy is complementary and part of a comprehensive approach to managing COPD. […] All patients who smoke and have COPD should be encouraged to quit, as treatment for COPD. […] When prescribing medication for patients with COPD: Choose medications based on severity. […] Evaluate the patient’s adherence and inhaler technique regularly, as up to 50% of patients use their device incorrectly. […] An ICS is typically added to a medication regimen last, due to an increased risk of pneumonia. […] The use of blood eosinophil counts to help guide therapy with ICS for patients with exacerbations is an emerging practice. […] A high eosinophil count (0.3 x 109/L) indicates a patient will likely respond well to ICS treatment, resulting in fewer acute exacerbations. […] More than 80% of exacerbations can be managed on an outpatient basis with pharmacologic therapies.
  • #29 Chronic Obstructive Pulmonary Disease (COPD): Diagnosis and Management – Province of British Columbia
    https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/copd
    Non-pharmacological therapy is complementary and part of a comprehensive approach to managing COPD. […] All patients who smoke and have COPD should be encouraged to quit, as treatment for COPD. […] When prescribing medication for patients with COPD: Choose medications based on severity. […] Evaluate the patient’s adherence and inhaler technique regularly, as up to 50% of patients use their device incorrectly. […] An ICS is typically added to a medication regimen last, due to an increased risk of pneumonia. […] The use of blood eosinophil counts to help guide therapy with ICS for patients with exacerbations is an emerging practice. […] A high eosinophil count (0.3 x 109/L) indicates a patient will likely respond well to ICS treatment, resulting in fewer acute exacerbations. […] More than 80% of exacerbations can be managed on an outpatient basis with pharmacologic therapies.
  • #30 COPD – Treatment | NHLBI, NIH
    https://www.nhlbi.nih.gov/health/copd/treatment
    If your COPD is moderate or severe, you may need long-acting bronchodilators that last about 12 hours or more or an anti-inflammatory. You take these every day. A new medication approved in 2024 combines a bronchodilator with a medicine that reduces inflammation (nonsteroid). The medication also helps the body clear mucus. […] If your COPD is severe or your symptoms flare up often, your provider may prescribe a combination of bronchodilators along with an inhaled steroid. Steroids help reduce the inflammation or swelling in your airways that makes it hard to breathe. If a combination of inhaled medicines does not help, an add-on medication, which is used in people with asthma and was approved in 2024 for COPD, may improve your breathing. Antibiotics may be used to treat flare-ups caused by an infection. Be sure to discuss a plan with your provider for treating a flare-up, including any special medicine you might need.
  • #31 Managing Your COPD Medications | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treating/copd-medications
    In people with severe air flow limitation, more symptoms, blood eosinophil counts 100 cells/L or with a history of COPD exacerbations, your healthcare provider may recommend triple therapy. Triple therapy combines an inhaled corticosteroid (ICS), long-acting beta-agonists (LABA) and long-acting anticholinergics (LAMA) in one medication. […] Biologic medicine was approved by the FDA in September 2024, as an add-on maintenance treatment option for some people living with COPD. Biologic medicine is used to treat COPD symptoms by targeting eosinophilic inflammation (eosinophils are a type of white blood cell associated with symptoms) which are present in some patients living with COPD. […] Medication does not cure COPD, but it can help improve your symptoms, reduce frequency and severity of flare ups or exacerbations, and help you stay more active. The goal is for you to be able to take the right medicine at the right time with the right technique.
  • #32 Chronic obstructive pulmonary disease (COPD) – Management Approach | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/7/management-approach
    Recommended escalation therapy for patients with persistent exacerbations after initial therapy is as follows: Patients taking long-acting bronchodilator monotherapy should increase therapy to LABA/LAMA. […] American Thoracic Society guidelines recommend the use of triple therapy in patients who have had one or more exacerbations requiring oral corticosteroids, antibiotics, or hospitalization in the past year and who have symptoms of dyspnea or reduced exercise tolerance despite LABA/LAMA dual therapy. […] Patients who take LABA/LAMA and whose blood eosinophils are 100 cells/microliter should escalate to triple therapy with LABA/LAMA/ICS. […] All patients are candidates for education, vaccination, and smoking cessation interventions. […] When indicated in patients with COPD, ICS should always be prescribed in combination with long-acting bronchodilators.
  • #33 List of 45 COPD Medications Compared
    https://www.drugs.com/condition/chronic-obstructive-pulmonary-disease.html
    COPD (Chronic Obstructive Pulmonary Disease) is a long-term respiratory condition that often requires several different medications to control it, such as bronchodilators (short-acting or long-acting), corticosteroids, mucolytics, or antibiotics. […] In addition to bronchodilators, anti-inflammatory medications, notably inhaled corticosteroids (ICS), play a role in COPD management. While not typically recommended as a standalone treatment, ICS are often prescribed in combination therapy for those with moderate to severe COPD. […] For individuals with severe airway limitations, persistent symptoms, high blood eosinophil counts, or a history of exacerbations, healthcare providers may recommend triple therapy. This involves combining an ICS, a LABA, and a LAMA into a single medication. An example is fluticasone/vilanterol/umeclidinium (Trelegy Ellipta). […] Exacerbations, characterized by increased coughing, mucus production, and shortness of breath, may require antibiotics or steroids. […] COPD patients should stay current on their vaccinations, including flu, COVID-19, and pneumonia shots (Prevnar 13, Pneumovax 23).
  • #34
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/
    If you’re still becoming breathless when using a long-acting inhaler, or you have frequent flare-ups (exacerbations), a GP may suggest including a steroid inhaler as part of your treatment. […] If your symptoms are not controlled with inhalers, a doctor may recommend taking tablets or capsules as well. […] If you have a particularly bad flare-up, you may be prescribed a short course of steroid tablets to reduce the inflammation in your airways. […] Pulmonary rehabilitation is a specialised programme of exercise and education designed to help people with lung problems such as COPD. […] Nebulised medicine may be used in severe cases of COPD if inhalers have not worked. […] Roflumilast is a new medicine that can be used to treat flare-ups. […] If COPD causes a low level of oxygen in your blood, you may be advised to have oxygen at home through nasal tubes or a mask. […] Surgery is usually only suitable for a small number of people with severe COPD whose symptoms are not controlled with medicine.
  • #35 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Bronchodilators are medicines that usually come in inhalers. Bronchodilators relax the muscles around the airways. This can help relieve coughing and make breathing easier. […] Inhaled corticosteroids, often simply called steroids, can lessen airway inflammation and help prevent bouts when COPD symptoms get worse. […] For times when COPD symptoms get worse, short courses of oral corticosteroids for example, 3 to 5 days may prevent more worsening of COPD. […] A medicine approved for severe COPD and symptoms of chronic bronchitis is roflumilast (Daliresp), a phosphodiesterase-4 inhibitor. This medicine lessens airway inflammation and relaxes the airways. […] Oxygen therapy, a pulmonary rehabilitation program and in-home noninvasive ventilation therapy can all help treat COPD. […] These programs usually combine health education, exercise training, breathing techniques, nutrition advice and counseling.
  • #36 COPD (Chronic Obstructive Pulmonary Disease): Overview
    https://patient.info/chest-lungs/chronic-obstructive-pulmonary-disease-leaflet
    The main treatments are medications given in devices called inhalers. […] A bronchodilator agent – this is a medicine which opens up (dilates) the airways. […] A steroid – these reduce the inflammation in the airway, thereby reducing the swelling. […] A mucolytic medicine such as carbocisteine and erdosteine makes the phlegm (sputum) less thick and sticky, and easier to cough up. […] A programme called 'pulmonary rehabilitation’ has been shown to be of benefit for people with moderate COPD. […] Treatment involves adding extra medicines temporarily to your usual treatment. This is usually steroid tablets with or without antibiotics. […] Palliative care means care or treatment to keep a person as comfortable as possible – to reduce the severity of the disease, rather than to cure it.
  • #37 Chronic obstructive pulmonary disease (COPD)
    https://info.health.nz/conditions-treatments/lungs/chronic-obstructive-pulmonary-disease
    COPD is treatable. The most important way to treat it is to stop smoking if you are a smoker. […] While COPD cannot be cured, treatment can prevent it getting worse and help with your symptoms. […] A specialised exercise and education programme known as pulmonary rehabilitation is an important part of treatment. Classes teach you about COPD, how to manage it, and exercises you can do to improve your breathing. […] The type of medication that is best for you will depend on how severe your COPD is and any other medical conditions you have. […] People with COPD are often given inhalers, which are devices that deliver medication to your lungs. […] If you have a flare-up, you will normally be given antibiotics and sometimes prednisone (steroid tablets). […] These medications are called mucolytics. They help make your mucus easier to cough up.
  • #38 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Bronchodilators are medicines that usually come in inhalers. Bronchodilators relax the muscles around the airways. This can help relieve coughing and make breathing easier. […] Inhaled corticosteroids, often simply called steroids, can lessen airway inflammation and help prevent bouts when COPD symptoms get worse. […] For times when COPD symptoms get worse, short courses of oral corticosteroids for example, 3 to 5 days may prevent more worsening of COPD. […] A medicine approved for severe COPD and symptoms of chronic bronchitis is roflumilast (Daliresp), a phosphodiesterase-4 inhibitor. This medicine lessens airway inflammation and relaxes the airways. […] Oxygen therapy, a pulmonary rehabilitation program and in-home noninvasive ventilation therapy can all help treat COPD. […] These programs usually combine health education, exercise training, breathing techniques, nutrition advice and counseling.
  • #39 Treatment of Acute COPD Exacerbation – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/treatment-of-acute-copd-exacerbation
    Noninvasive positive-pressure ventilation (eg, pressure support or positive airway pressure ventilation by face mask) is an alternative to full mechanical ventilation. […] Noninvasive ventilation appears to decrease the need for intubation, reduce hospital stay, and reduce mortality in patients with severe exacerbations. […] Beta-agonists and anticholinergics, with or without corticosteroids, should be started concurrently with oxygen therapy with the aim of reversing airway obstruction. […] Short-acting beta-agonists are the cornerstone of medication therapy for acute exacerbations. […] Corticosteroids should be begun immediately for all but mild exacerbations. […] Antibiotics are recommended for exacerbations in patients with purulent sputum. […] Most patients hospitalized with exacerbation of chronic obstructive pulmonary disease (COPD) require oxygen supplementation during an exacerbation. […] Inhaled short-acting beta-agonists are the cornerstone of medication therapy for acute exacerbations. […] Use antibiotics if patients have acute exacerbations and purulent sputum.
  • #40 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Bronchodilators are medicines that usually come in inhalers. Bronchodilators relax the muscles around the airways. This can help relieve coughing and make breathing easier. […] Inhaled corticosteroids, often simply called steroids, can lessen airway inflammation and help prevent bouts when COPD symptoms get worse. […] For times when COPD symptoms get worse, short courses of oral corticosteroids for example, 3 to 5 days may prevent more worsening of COPD. […] A medicine approved for severe COPD and symptoms of chronic bronchitis is roflumilast (Daliresp), a phosphodiesterase-4 inhibitor. This medicine lessens airway inflammation and relaxes the airways. […] Oxygen therapy, a pulmonary rehabilitation program and in-home noninvasive ventilation therapy can all help treat COPD. […] These programs usually combine health education, exercise training, breathing techniques, nutrition advice and counseling.
  • #41 Chronic Obstructive Pulmonary Disease (COPD) – Treatment : Emergency Care BC
    https://emergencycarebc.ca/clinical_resource/clinical-summary/chronic-obstructive-pulmonary-disease-treatment/
    Chronic Obstructive Pulmonary Disease (COPD) – Treatment […] Acute Exacerbations of COPD (AECOPD) negatively impact health status and disease progression. […] More than 80% of exacerbations are managed on an outpatient basis with pharmacological therapies including bronchodilators, corticosteroids, and antibiotics. […] Oxygen: Titrate oxygen saturation to 88-92%. Avoid overoxygenation. […] Bronchodilators: Short-acting beta2-agonists, with or without short-acting anticholinergics. No difference between both or their combination. No difference in clinical outcomes between inhaled use with a spacer and nebulized administration of these agents. […] Corticosteroids: Improve lung function, oxygenation, risk of early relapse, treatment failure, and the length of hospitalization. Duration: 5-7 days. Oral is equivalent to intravenous. Choice based on patient’s clinical condition. […] Antibiotics: Recommended for patients with: all three cardinal symptoms: increase in dyspnea, sputum volume, and sputum purulence; two cardinal symptoms, if increased purulence of sputum is a symptom; require mechanical ventilation (invasive or noninvasive). Strong benefit among patients admitted to ICU. Duration: 5-7 days. Adjust to local antibiogram. […] Non-Invasive Ventilation (NIV): First-line in patients admitted with acute hypercapnic respiratory failure: Improves gas exchange, work of breathing, mortality and intubation rate. BiPAP is preferred to CPAP. […] Indications for Mechanical Ventilation: NIV contraindication or failure. Respiratory or cardiac arrest. Worsening respiratory fatigue. Decreased level of consciousness. Hemodynamic instability. Persistent hypoxemia. […] Patients treated as outpatients should receive: Education: Inhaler technique. Use of a spacer. Smoking cessation assistance. Vaccinations. Strategies to prevent further exacerbations. […] Medical management: Short-acting inhaled beta-2 agonists, with or without short-acting anticholinergics. Corticosteroid short course. Antibiotics (patients with a change in their sputum). Long-acting inhaled bronchodilators with or without inhaled corticosteroids. […]
  • #42 Promising cure for COPD: is a breakthrough within reach?
    https://www.labiotech.eu/in-depth/copd-cure-breakthrough-treatments/
    Ohtuvayre is a selective dual inhibitor of the phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4) enzymes, combining two properties in one medicine, which ultimately sets it apart in COPD for its ability to both open the airways of patients and reduce inflammation. […] And, just last month, there was another big win for COPD patients, as Regeneron and Sanofi announced that the FDA had expanded the label of their drug Dupixent to treat COPD. […] Although the approvals of Ohtuvayre and Dupixent signify great news for COPD patients, they are not cures for the disease. […] Looking ahead, the researchers are now planning a phase 2 trial of the treatment, which will evaluate its efficacy in a larger group of patients. […] Although COPD does not yet have a cure and there was a long lull in therapeutic advancements until recently, the future now looks promising when it comes to treatment options for the disease.
  • #43 DUPIXENT® (dupilumab) for Adults with COPD
    https://www.dupixent.com/copd/
    DUPIXENT is an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and a high number of blood eosinophils (a type of white blood cell that may contribute to your COPD). […] WHEN USED WITH COPD INHALERS,* DUPIXENT CAN: Help people breathe easier starting in as little as 2 weeks Help block a key source of inflammation Lead to improvement in patients day-to-day lives Help reduce flare-ups. […] Assessed by SGRQ, a quality of life tool which measures COPD symptoms, physical activity, emotional well-being, and social functioning. In two trials, 51% of patients who received DUPIXENT + SOC experienced a quality of life improvement vs 43% and 47% with placebo + SOC.
  • #44 Promising cure for COPD: is a breakthrough within reach?
    https://www.labiotech.eu/in-depth/copd-cure-breakthrough-treatments/
    Ohtuvayre is a selective dual inhibitor of the phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4) enzymes, combining two properties in one medicine, which ultimately sets it apart in COPD for its ability to both open the airways of patients and reduce inflammation. […] And, just last month, there was another big win for COPD patients, as Regeneron and Sanofi announced that the FDA had expanded the label of their drug Dupixent to treat COPD. […] Although the approvals of Ohtuvayre and Dupixent signify great news for COPD patients, they are not cures for the disease. […] Looking ahead, the researchers are now planning a phase 2 trial of the treatment, which will evaluate its efficacy in a larger group of patients. […] Although COPD does not yet have a cure and there was a long lull in therapeutic advancements until recently, the future now looks promising when it comes to treatment options for the disease.
  • #45 COPD Medications
    https://www.webmd.com/lung/copd/copd-medications
    Sometimes your doctor recommends an inhaler or nebulizer that contains more than one medication. […] Your doctor may prescribe an antibiotic if you have a bacterial respiratory infection like bronchitis or pneumonia. These infections can make your COPD worse. […] Ensifentrine (Ohtuvayre), is an inhaled phosphodiesterase (PDE) 3 and PDE4 inhibitor that you use twice a day to help keep your airways open. […] These medications make your mucus (or phlegm) thinner so you can cough it up more easily. […] You need a prescription to get relief from most COPD symptoms. Over-the-counter inhalers aren’t meant to be used for COPD. […] Researchers are studying some new drugs that might work to treat COPD.
  • #46 Treating COPD | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treating
    Pulmonary rehab programs may help improve your lung function, reduce symptoms and the risk of hospital admissions, and improve your quality of life. […] Supplemental oxygen or oxygen therapy increases the amount of oxygen that flows into your lungs. […] Non-invasive ventilation is a form of noninvasive positive pressure ventilation (NPPV) and may decrease mortality and prevent re-hospitalization. […] Endobronchial valve therapy or EBVs are a non-surgical approach for select people living with advanced COPD and emphysema breathe easier. […] In some of these cases, healthcare providers may suggest lung surgery to improve breathing. […] Clinical trials are research studies that test how well new medical approaches work in people. […] Complementary therapies refer to the many therapies, philosophies and practices that are not considered conventional or standard medical care in the United States. […] Palliative care is a specialty in medicine that focuses on relieving the discomfort of symptoms, anxiety, pain and stress that accompany serious illnesses like COPD. […] Advanced directives are medical treatment and care decisions written out ahead of time.
  • #47 Chronic Obstructive Pulmonary Disease (COPD) Treatment & Management: Approach Considerations, Smoking Cessation, Management of Inflammation
    https://emedicine.medscape.com/article/297664-treatment
    Long-term oxygen therapy improves survival 2-fold or more in hypoxemic patients with COPD, according to 2 landmark trials, the British Medical Research Council (MRC) study and the US National Heart, Lung and Blood Institutes Nocturnal Oxygen Therapy Trial (NOTT). […] Noninvasive positive-pressure ventilation (NIPPV), as the name suggests, allows the delivery of positive-pressure ventilation without the use of an endotracheal tube. […] Vaccinations are a safe and effective modality to reduce infections in susceptible COPD patients. The pneumococcal vaccine should be offered to all patients older than 65 years or to patients of any age who have an FEV1 of less than 40% of predicted. The influenza vaccine should be given annually to all COPD patients. […] The treatment strategies for AAT deficiency involve reducing the neutrophil elastase burden, primarily by smoking cessation, and augmenting the levels of AAT. Available augmentation strategies include pharmacologic attempts to increase endogenous production of AAT by the liver and administration of purified AAT by periodic intravenous infusion or by inhalation.
  • #48 Chronic obstructive pulmonary disease (COPD) – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-gb/7
    Chronic obstructive pulmonary disease (COPD) is suspected in patients with a history of smoking, occupational and environmental risk factors, or a personal or family history of chronic lung disease. […] Treatment options include bronchodilators, inhaled corticosteroids, phosphodiesterase-4 inhibitors, antibiotics, and mucolytics. Pulmonary rehabilitation improves exercise tolerance, dyspnoea, and health-related quality of life, and reduces re-hospitalisations and mortality. […] Long-term oxygen therapy improves survival in severe COPD.
  • #49 COPD Treatment: Therapy, Surgery, and Lifestyle Changes
    https://www.healthline.com/health/copd/treatment-options
    Corticosteroids, such as prednisone, reduce irritation and swelling in your airways. […] If you have a respiratory infection, which is often the case when symptoms suddenly worsen, a healthcare professional may prescribe antibiotics. […] Treating anxiety symptoms is key to decreasing the discomfort that often accompanies shortness of breath. […] Opioids, also known as narcotic medications or pain relievers, work by depressing the central nervous system. Opioid medication can help ease that feeling of air hunger. […] Supplemental oxygen and pulmonary rehabilitation may be especially beneficial for this age group. […] Oxygen therapy can help you: stay active with fewer symptoms, protect your heart and other organs from further damage caused by oxygen deprivation, sleep better and be more alert during waking hours, live longer.
  • #50 Treatment of Stable COPD – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/treatment-of-stable-copd
    The frequency of exacerbations can be reduced with the use of anticholinergics, inhaled corticosteroids, or long-acting beta-agonists. […] For home treatment of chronic stable disease, medication administration by metered-dose inhaler or dry-powder inhaler is preferred over administration by nebulizer. […] Inhaled corticosteroids seem to reduce airway inflammation, reverse beta-receptor down-regulation, and inhibit leukotriene and cytokine production. […] They are indicated for patients who have repeated exacerbations or symptoms despite optimal bronchodilator therapy. […] Long-term oxygen therapy prolongs life in patients with COPD whose partial pressure of arterial oxygen (PaO2) is chronically 55 mm Hg. […] Oxygen therapy does the following: brings hematocrit toward normal levels, improves neuropsychologic factors, ameliorates pulmonary hemodynamic abnormalities, and increases exercise tolerance in some patients.
  • #51 Treatment of Acute COPD Exacerbation – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/treatment-of-acute-copd-exacerbation
    Noninvasive positive-pressure ventilation (eg, pressure support or positive airway pressure ventilation by face mask) is an alternative to full mechanical ventilation. […] Noninvasive ventilation appears to decrease the need for intubation, reduce hospital stay, and reduce mortality in patients with severe exacerbations. […] Beta-agonists and anticholinergics, with or without corticosteroids, should be started concurrently with oxygen therapy with the aim of reversing airway obstruction. […] Short-acting beta-agonists are the cornerstone of medication therapy for acute exacerbations. […] Corticosteroids should be begun immediately for all but mild exacerbations. […] Antibiotics are recommended for exacerbations in patients with purulent sputum. […] Most patients hospitalized with exacerbation of chronic obstructive pulmonary disease (COPD) require oxygen supplementation during an exacerbation. […] Inhaled short-acting beta-agonists are the cornerstone of medication therapy for acute exacerbations. […] Use antibiotics if patients have acute exacerbations and purulent sputum.
  • #52 Treating COPD | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treating
    Pulmonary rehab programs may help improve your lung function, reduce symptoms and the risk of hospital admissions, and improve your quality of life. […] Supplemental oxygen or oxygen therapy increases the amount of oxygen that flows into your lungs. […] Non-invasive ventilation is a form of noninvasive positive pressure ventilation (NPPV) and may decrease mortality and prevent re-hospitalization. […] Endobronchial valve therapy or EBVs are a non-surgical approach for select people living with advanced COPD and emphysema breathe easier. […] In some of these cases, healthcare providers may suggest lung surgery to improve breathing. […] Clinical trials are research studies that test how well new medical approaches work in people. […] Complementary therapies refer to the many therapies, philosophies and practices that are not considered conventional or standard medical care in the United States. […] Palliative care is a specialty in medicine that focuses on relieving the discomfort of symptoms, anxiety, pain and stress that accompany serious illnesses like COPD. […] Advanced directives are medical treatment and care decisions written out ahead of time.
  • #53
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/
    If you’re still becoming breathless when using a long-acting inhaler, or you have frequent flare-ups (exacerbations), a GP may suggest including a steroid inhaler as part of your treatment. […] If your symptoms are not controlled with inhalers, a doctor may recommend taking tablets or capsules as well. […] If you have a particularly bad flare-up, you may be prescribed a short course of steroid tablets to reduce the inflammation in your airways. […] Pulmonary rehabilitation is a specialised programme of exercise and education designed to help people with lung problems such as COPD. […] Nebulised medicine may be used in severe cases of COPD if inhalers have not worked. […] Roflumilast is a new medicine that can be used to treat flare-ups. […] If COPD causes a low level of oxygen in your blood, you may be advised to have oxygen at home through nasal tubes or a mask. […] Surgery is usually only suitable for a small number of people with severe COPD whose symptoms are not controlled with medicine.
  • #54 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Bronchodilators are medicines that usually come in inhalers. Bronchodilators relax the muscles around the airways. This can help relieve coughing and make breathing easier. […] Inhaled corticosteroids, often simply called steroids, can lessen airway inflammation and help prevent bouts when COPD symptoms get worse. […] For times when COPD symptoms get worse, short courses of oral corticosteroids for example, 3 to 5 days may prevent more worsening of COPD. […] A medicine approved for severe COPD and symptoms of chronic bronchitis is roflumilast (Daliresp), a phosphodiesterase-4 inhibitor. This medicine lessens airway inflammation and relaxes the airways. […] Oxygen therapy, a pulmonary rehabilitation program and in-home noninvasive ventilation therapy can all help treat COPD. […] These programs usually combine health education, exercise training, breathing techniques, nutrition advice and counseling.
  • #55 Chronic obstructive pulmonary disease (COPD) – Management Approach | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/7/management-approach
    Pulmonary rehabilitation comprises aerobic exercise, strength training, and education. […] GOLD guidelines recommend pulmonary rehabilitation for patients with high symptom burden and risk of exacerbation. […] Extensive pulmonary rehabilitation following hospital admission with an acute exacerbation of COPD decreases the risk of readmission, improves health-related quality of life, and reduces mortality. […] Supplemental oxygen should be titrated to achieve SaO 90%. […] Among different therapeutic modalities in COPD, the only two factors that improve survival are smoking cessation and oxygen supplementation. […] Surgical interventions are the last step in the management of COPD, and include bullectomy, lung volume reduction surgery, and lung transplant. […] Lung transplantation has been shown to improve quality of life and functional capacity. […] Palliative therapies to improve symptoms of dyspnea, offer nutritional support, address anxiety and depression, and reduce fatigue may benefit patients with COPD who experience these despite optimal medical therapy.
  • #56 Treating COPD | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treating
    Pulmonary rehab programs may help improve your lung function, reduce symptoms and the risk of hospital admissions, and improve your quality of life. […] Supplemental oxygen or oxygen therapy increases the amount of oxygen that flows into your lungs. […] Non-invasive ventilation is a form of noninvasive positive pressure ventilation (NPPV) and may decrease mortality and prevent re-hospitalization. […] Endobronchial valve therapy or EBVs are a non-surgical approach for select people living with advanced COPD and emphysema breathe easier. […] In some of these cases, healthcare providers may suggest lung surgery to improve breathing. […] Clinical trials are research studies that test how well new medical approaches work in people. […] Complementary therapies refer to the many therapies, philosophies and practices that are not considered conventional or standard medical care in the United States. […] Palliative care is a specialty in medicine that focuses on relieving the discomfort of symptoms, anxiety, pain and stress that accompany serious illnesses like COPD. […] Advanced directives are medical treatment and care decisions written out ahead of time.
  • #57 Management of chronic obstructive pulmonary disease: A review focusing on exacerbations
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7005599/
    Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity and mortality in the United States. Exacerbations acute worsening of COPD symptoms can be mild to severe in nature. Increased healthcare resource use is common among patients with frequent exacerbations, and exacerbations are a major cause of the high 30-day hospital readmission rates associated with COPD. […] Timely and appropriate maintenance pharmacotherapy, particularly dual bronchodilators for maximizing bronchodilation, can significantly reduce exacerbations in patients with COPD. Additionally, multidisciplinary disease-management programs include pulmonary rehabilitation, follow-up appointments, aftercare, inhaler training, and patient education that can reduce hospitalizations and readmissions for patients with COPD.
  • #58 Guide | Physical Therapy Guide to Chronic Obstructive Pulmonary Disease (COPD) | Choose PT
    https://www.choosept.com/guide/physical-therapy-guide-chronic-obstructive-pulmonary-disease-copd
    Chronic obstructive pulmonary disease, or COPD, is a lung condition that involves prolonged respiratory symptoms. These symptoms include shortness of breath, cough, and sputum (phlegm) production that can limit a persons activity. […] Physical therapists help people with COPD improve their symptoms and restore strength in their breathing muscles. They help them build breathing efficiency, increase activity tolerance, and reduce fatigue through guided exercise programs. […] Research shows that pulmonary (lung) rehabilitation, including exercise training for at least four weeks, improves shortness of breath and quality of life. It also provides strategies for coping with COPD. Your physical therapist will serve as an important member of your health care team. […] Your physical therapy treatment plan will include strategies to:
  • #59 COPD Treatment: Therapy, Surgery, and Lifestyle Changes
    https://www.healthline.com/health/copd/treatment-options
    Pulmonary rehabilitation often involves a team of doctors and specialists. The primary goal is to help you stay active through increased stamina. […] Surgery may be beneficial for a small percentage of people with COPD and is usually only an option in severe cases. […] A new method of treating COPD is a minimally invasive procedure called bronchial rheoplasty. […] For some people with COPD or severe asthma, failure to respond to the anti-inflammatory effects of corticosteroids can be a major barrier to effective treatment. […] People who quit smoking can improve their health and overall quality of life. […] Effective end-of-life care involves: pain and symptom management, provisions of spiritual, psychological, social, and practical support, an active partnership of care involving you, your loved ones, and your team of healthcare professionals. […] Seek immediate medical attention if your regular treatments arent helping with the following symptoms: unusual difficulty walking or talking, fast or irregular heart rate, new or worsening chest pain, blue lips or fingernails, hard and fast breathing.
  • #60 COPD Treatment: Therapy, Surgery, and Lifestyle Changes
    https://www.healthline.com/health/copd/treatment-options
    Pulmonary rehabilitation often involves a team of doctors and specialists. The primary goal is to help you stay active through increased stamina. […] Surgery may be beneficial for a small percentage of people with COPD and is usually only an option in severe cases. […] A new method of treating COPD is a minimally invasive procedure called bronchial rheoplasty. […] For some people with COPD or severe asthma, failure to respond to the anti-inflammatory effects of corticosteroids can be a major barrier to effective treatment. […] People who quit smoking can improve their health and overall quality of life. […] Effective end-of-life care involves: pain and symptom management, provisions of spiritual, psychological, social, and practical support, an active partnership of care involving you, your loved ones, and your team of healthcare professionals. […] Seek immediate medical attention if your regular treatments arent helping with the following symptoms: unusual difficulty walking or talking, fast or irregular heart rate, new or worsening chest pain, blue lips or fingernails, hard and fast breathing.
  • #61 COPD: Treatment Advances | Montefiore Nyack
    https://www.montefiorenyack.org/health-blog/copd-treatment-advances
    Many COPD patients used to need three different inhalers daily to manage their disease. Now, there are several Food and Drug Administration (FDA)-approved inhalers that combine all three medications in one. Recent studies have shown that combining all three medications in one inhaler allows people to breathe better, reduces COPD flare-ups and improves survival, Dr. Krishna said. A person just needs to use the inhaler once a dayits a big advance for people with COPD. […] Another important part of COPD treatment is pulmonary rehabilitation. This is a program of educational classes and supervised exercise sessions for people with COPD and other chronic breathing problems. A person works with a respiratory therapist two or three times a week, using special equipment. Pulmonary rehab can have a tremendous impact on patients with COPD, Dr. Krishna said. The majority of patients come out feeling stronger and better. They can do more and are less short of breath. Montefiore Nyack Hospital is planning to open a pulmonary rehabilitation center early in 2022, Dr. Krishna said.
  • #62 Medical Therapy for Chronic Obstructive Pulmonary Disease | NYU Langone Health
    https://nyulangone.org/conditions/chronic-obstructive-pulmonary-disease/treatments/medical-therapy-for-chronic-obstructive-pulmonary-disease
    There is no cure for chronic obstructive pulmonary disease, or COPD, but treatment can help slow the progression of the condition. […] NYU Langone specialists may recommend several different therapies to manage COPD and prevent it from worsening. Medical therapies are often recommended in conjunction with medication for COPD. […] The Pulmonary Rehabilitation Program at NYU Langones Rusk Rehabilitation offers people with COPD an evaluation from a certified physical therapist or exercise physiologist, who specializes in how exercise affects body mechanics. […] Your rehabilitation program also involves breathing exercises. Diaphragmatic breathingin which you focus on using the diaphragm, the muscle that separates the chest from the abdomen, to breathecan help keep the airways open, control shortness of breath, and relax the body. […] In airway clearance therapy, manual techniques and devices are used to prevent mucus from building up in the airways. […] For people with low blood oxygen levels due to COPD, oxygen therapy is the only treatment that has been shown to prolong life.
  • #63 Guide | Physical Therapy Guide to Chronic Obstructive Pulmonary Disease (COPD) | Choose PT
    https://www.choosept.com/guide/physical-therapy-guide-chronic-obstructive-pulmonary-disease-copd
    Improve your breathing. People with COPD often have shortness of breath and reduced strength in the muscles used to breath in air. Your physical therapist can help you train your breathing muscles to reduce shortness of breath and increase exercise capacity. […] Improve your ability to be physically active. Your physical therapist will design an exercise program to train the muscles you use for movement. […] Regular physical activity can benefit your physical, mental, and social health. […] Improve your balance. The decrease in function and mobility that occurs in people with COPD can cause balance problems. […] If you already have COPD, your physical therapist can guide you to help keep it from getting worse. […] Continuing regular exercise after pulmonary rehabilitation for COPD helps slow the decline in quality of life and shortness of breath during everyday activities.
  • #64 Overview of the Diagnosis and Treatment of COPD Exacerbations
    https://www.uspharmacist.com/article/overview-of-the-diagnosis-and-treatment-of-copd-exacerbations
    Chronic obstructive pulmonary disease (COPD) poses a significant global health burden. […] AECOPD treatment includes antibiotics, corticosteroids, and bronchodilators. […] Nonpharmacologic treatments not only can help relieve patients AECOPD symptoms but may also prevent future exacerbations. […] Currently, guidelines recommend antibiotics for AECOPD in the following three scenarios: patients who have the three cardinal symptoms of increased sputum volume, sputum purulence, and dyspnea; patients who have two of the three cardinal symptoms, one of these being increased sputum purulence; and patients who are on mechanical ventilation. […] Glucocorticoids benefit hospitalized AECOPD patients by enhancing oxygenation, improving recovery time, reducing the relapse risk, and shortening the length of hospital stay.
  • #65 Management of chronic obstructive pulmonary disease: A review focusing on exacerbations
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7005599/
    The preference for long-acting muscarinic antagonist (LAMA)/long-acting 2-agonist (LABA) combinations over inhaled corticosteroid (ICS)-containing regimens is supported by evidence from several studies. […] A switch from LABA/ICS to LAMA/LABA is recommended if patients do not respond to ICS or where risks associated with ICS are a concern. […] Short-acting bronchodilators, particularly short-acting 2-agonists, are recommended for treatment of exacerbations and can be combined with short-acting anticholinergics. […] The addition of a systemic corticosteroid to the treatment regimen may be required for moderate-to-severe COPD exacerbations or those that do not respond to short-acting bronchodilators. […] According to Hurst and colleagues, exacerbations in COPD are not random events but occur in a high-risk period for recurrent exacerbation in the 8-week period following an initial exacerbation.
  • #66 Chronic Obstructive Pulmonary Disease (COPD) – Treatment : Emergency Care BC
    https://emergencycarebc.ca/clinical_resource/clinical-summary/chronic-obstructive-pulmonary-disease-treatment/
    Chronic Obstructive Pulmonary Disease (COPD) – Treatment […] Acute Exacerbations of COPD (AECOPD) negatively impact health status and disease progression. […] More than 80% of exacerbations are managed on an outpatient basis with pharmacological therapies including bronchodilators, corticosteroids, and antibiotics. […] Oxygen: Titrate oxygen saturation to 88-92%. Avoid overoxygenation. […] Bronchodilators: Short-acting beta2-agonists, with or without short-acting anticholinergics. No difference between both or their combination. No difference in clinical outcomes between inhaled use with a spacer and nebulized administration of these agents. […] Corticosteroids: Improve lung function, oxygenation, risk of early relapse, treatment failure, and the length of hospitalization. Duration: 5-7 days. Oral is equivalent to intravenous. Choice based on patient’s clinical condition. […] Antibiotics: Recommended for patients with: all three cardinal symptoms: increase in dyspnea, sputum volume, and sputum purulence; two cardinal symptoms, if increased purulence of sputum is a symptom; require mechanical ventilation (invasive or noninvasive). Strong benefit among patients admitted to ICU. Duration: 5-7 days. Adjust to local antibiogram. […] Non-Invasive Ventilation (NIV): First-line in patients admitted with acute hypercapnic respiratory failure: Improves gas exchange, work of breathing, mortality and intubation rate. BiPAP is preferred to CPAP. […] Indications for Mechanical Ventilation: NIV contraindication or failure. Respiratory or cardiac arrest. Worsening respiratory fatigue. Decreased level of consciousness. Hemodynamic instability. Persistent hypoxemia. […] Patients treated as outpatients should receive: Education: Inhaler technique. Use of a spacer. Smoking cessation assistance. Vaccinations. Strategies to prevent further exacerbations. […] Medical management: Short-acting inhaled beta-2 agonists, with or without short-acting anticholinergics. Corticosteroid short course. Antibiotics (patients with a change in their sputum). Long-acting inhaled bronchodilators with or without inhaled corticosteroids. […]
  • #67 Overview of the Diagnosis and Treatment of COPD Exacerbations
    https://www.uspharmacist.com/article/overview-of-the-diagnosis-and-treatment-of-copd-exacerbations
    Chronic obstructive pulmonary disease (COPD) poses a significant global health burden. […] AECOPD treatment includes antibiotics, corticosteroids, and bronchodilators. […] Nonpharmacologic treatments not only can help relieve patients AECOPD symptoms but may also prevent future exacerbations. […] Currently, guidelines recommend antibiotics for AECOPD in the following three scenarios: patients who have the three cardinal symptoms of increased sputum volume, sputum purulence, and dyspnea; patients who have two of the three cardinal symptoms, one of these being increased sputum purulence; and patients who are on mechanical ventilation. […] Glucocorticoids benefit hospitalized AECOPD patients by enhancing oxygenation, improving recovery time, reducing the relapse risk, and shortening the length of hospital stay.
  • #68 Chronic Obstructive Pulmonary Disease (COPD) – Treatment : Emergency Care BC
    https://emergencycarebc.ca/clinical_resource/clinical-summary/chronic-obstructive-pulmonary-disease-treatment/
    Chronic Obstructive Pulmonary Disease (COPD) – Treatment […] Acute Exacerbations of COPD (AECOPD) negatively impact health status and disease progression. […] More than 80% of exacerbations are managed on an outpatient basis with pharmacological therapies including bronchodilators, corticosteroids, and antibiotics. […] Oxygen: Titrate oxygen saturation to 88-92%. Avoid overoxygenation. […] Bronchodilators: Short-acting beta2-agonists, with or without short-acting anticholinergics. No difference between both or their combination. No difference in clinical outcomes between inhaled use with a spacer and nebulized administration of these agents. […] Corticosteroids: Improve lung function, oxygenation, risk of early relapse, treatment failure, and the length of hospitalization. Duration: 5-7 days. Oral is equivalent to intravenous. Choice based on patient’s clinical condition. […] Antibiotics: Recommended for patients with: all three cardinal symptoms: increase in dyspnea, sputum volume, and sputum purulence; two cardinal symptoms, if increased purulence of sputum is a symptom; require mechanical ventilation (invasive or noninvasive). Strong benefit among patients admitted to ICU. Duration: 5-7 days. Adjust to local antibiogram. […] Non-Invasive Ventilation (NIV): First-line in patients admitted with acute hypercapnic respiratory failure: Improves gas exchange, work of breathing, mortality and intubation rate. BiPAP is preferred to CPAP. […] Indications for Mechanical Ventilation: NIV contraindication or failure. Respiratory or cardiac arrest. Worsening respiratory fatigue. Decreased level of consciousness. Hemodynamic instability. Persistent hypoxemia. […] Patients treated as outpatients should receive: Education: Inhaler technique. Use of a spacer. Smoking cessation assistance. Vaccinations. Strategies to prevent further exacerbations. […] Medical management: Short-acting inhaled beta-2 agonists, with or without short-acting anticholinergics. Corticosteroid short course. Antibiotics (patients with a change in their sputum). Long-acting inhaled bronchodilators with or without inhaled corticosteroids. […]
  • #69 Chronic Obstructive Pulmonary Disease (COPD) – Treatment : Emergency Care BC
    https://emergencycarebc.ca/clinical_resource/clinical-summary/chronic-obstructive-pulmonary-disease-treatment/
    Chronic Obstructive Pulmonary Disease (COPD) – Treatment […] Acute Exacerbations of COPD (AECOPD) negatively impact health status and disease progression. […] More than 80% of exacerbations are managed on an outpatient basis with pharmacological therapies including bronchodilators, corticosteroids, and antibiotics. […] Oxygen: Titrate oxygen saturation to 88-92%. Avoid overoxygenation. […] Bronchodilators: Short-acting beta2-agonists, with or without short-acting anticholinergics. No difference between both or their combination. No difference in clinical outcomes between inhaled use with a spacer and nebulized administration of these agents. […] Corticosteroids: Improve lung function, oxygenation, risk of early relapse, treatment failure, and the length of hospitalization. Duration: 5-7 days. Oral is equivalent to intravenous. Choice based on patient’s clinical condition. […] Antibiotics: Recommended for patients with: all three cardinal symptoms: increase in dyspnea, sputum volume, and sputum purulence; two cardinal symptoms, if increased purulence of sputum is a symptom; require mechanical ventilation (invasive or noninvasive). Strong benefit among patients admitted to ICU. Duration: 5-7 days. Adjust to local antibiogram. […] Non-Invasive Ventilation (NIV): First-line in patients admitted with acute hypercapnic respiratory failure: Improves gas exchange, work of breathing, mortality and intubation rate. BiPAP is preferred to CPAP. […] Indications for Mechanical Ventilation: NIV contraindication or failure. Respiratory or cardiac arrest. Worsening respiratory fatigue. Decreased level of consciousness. Hemodynamic instability. Persistent hypoxemia. […] Patients treated as outpatients should receive: Education: Inhaler technique. Use of a spacer. Smoking cessation assistance. Vaccinations. Strategies to prevent further exacerbations. […] Medical management: Short-acting inhaled beta-2 agonists, with or without short-acting anticholinergics. Corticosteroid short course. Antibiotics (patients with a change in their sputum). Long-acting inhaled bronchodilators with or without inhaled corticosteroids. […]
  • #70 Chronic Obstructive Pulmonary Disease (COPD) – Treatment : Emergency Care BC
    https://emergencycarebc.ca/clinical_resource/clinical-summary/chronic-obstructive-pulmonary-disease-treatment/
    Chronic Obstructive Pulmonary Disease (COPD) – Treatment […] Acute Exacerbations of COPD (AECOPD) negatively impact health status and disease progression. […] More than 80% of exacerbations are managed on an outpatient basis with pharmacological therapies including bronchodilators, corticosteroids, and antibiotics. […] Oxygen: Titrate oxygen saturation to 88-92%. Avoid overoxygenation. […] Bronchodilators: Short-acting beta2-agonists, with or without short-acting anticholinergics. No difference between both or their combination. No difference in clinical outcomes between inhaled use with a spacer and nebulized administration of these agents. […] Corticosteroids: Improve lung function, oxygenation, risk of early relapse, treatment failure, and the length of hospitalization. Duration: 5-7 days. Oral is equivalent to intravenous. Choice based on patient’s clinical condition. […] Antibiotics: Recommended for patients with: all three cardinal symptoms: increase in dyspnea, sputum volume, and sputum purulence; two cardinal symptoms, if increased purulence of sputum is a symptom; require mechanical ventilation (invasive or noninvasive). Strong benefit among patients admitted to ICU. Duration: 5-7 days. Adjust to local antibiogram. […] Non-Invasive Ventilation (NIV): First-line in patients admitted with acute hypercapnic respiratory failure: Improves gas exchange, work of breathing, mortality and intubation rate. BiPAP is preferred to CPAP. […] Indications for Mechanical Ventilation: NIV contraindication or failure. Respiratory or cardiac arrest. Worsening respiratory fatigue. Decreased level of consciousness. Hemodynamic instability. Persistent hypoxemia. […] Patients treated as outpatients should receive: Education: Inhaler technique. Use of a spacer. Smoking cessation assistance. Vaccinations. Strategies to prevent further exacerbations. […] Medical management: Short-acting inhaled beta-2 agonists, with or without short-acting anticholinergics. Corticosteroid short course. Antibiotics (patients with a change in their sputum). Long-acting inhaled bronchodilators with or without inhaled corticosteroids. […]
  • #71 Chronic Obstructive Pulmonary Disease (COPD) – Treatment : Emergency Care BC
    https://emergencycarebc.ca/clinical_resource/clinical-summary/chronic-obstructive-pulmonary-disease-treatment/
    Chronic Obstructive Pulmonary Disease (COPD) – Treatment […] Acute Exacerbations of COPD (AECOPD) negatively impact health status and disease progression. […] More than 80% of exacerbations are managed on an outpatient basis with pharmacological therapies including bronchodilators, corticosteroids, and antibiotics. […] Oxygen: Titrate oxygen saturation to 88-92%. Avoid overoxygenation. […] Bronchodilators: Short-acting beta2-agonists, with or without short-acting anticholinergics. No difference between both or their combination. No difference in clinical outcomes between inhaled use with a spacer and nebulized administration of these agents. […] Corticosteroids: Improve lung function, oxygenation, risk of early relapse, treatment failure, and the length of hospitalization. Duration: 5-7 days. Oral is equivalent to intravenous. Choice based on patient’s clinical condition. […] Antibiotics: Recommended for patients with: all three cardinal symptoms: increase in dyspnea, sputum volume, and sputum purulence; two cardinal symptoms, if increased purulence of sputum is a symptom; require mechanical ventilation (invasive or noninvasive). Strong benefit among patients admitted to ICU. Duration: 5-7 days. Adjust to local antibiogram. […] Non-Invasive Ventilation (NIV): First-line in patients admitted with acute hypercapnic respiratory failure: Improves gas exchange, work of breathing, mortality and intubation rate. BiPAP is preferred to CPAP. […] Indications for Mechanical Ventilation: NIV contraindication or failure. Respiratory or cardiac arrest. Worsening respiratory fatigue. Decreased level of consciousness. Hemodynamic instability. Persistent hypoxemia. […] Patients treated as outpatients should receive: Education: Inhaler technique. Use of a spacer. Smoking cessation assistance. Vaccinations. Strategies to prevent further exacerbations. […] Medical management: Short-acting inhaled beta-2 agonists, with or without short-acting anticholinergics. Corticosteroid short course. Antibiotics (patients with a change in their sputum). Long-acting inhaled bronchodilators with or without inhaled corticosteroids. […]
  • #72 Chronic Obstructive Pulmonary Disease (COPD): Diagnosis and Management – Province of British Columbia
    https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/copd
    Develop an exacerbation action plan with patients. […] Pharmacologic therapies for AECOPD may include: Short-acting bronchodilator for initial treatment of acute exacerbation, Oral corticosteroids for most moderate to severe COPD patients. […] Systemic corticosteroids in AECOPD shorten recovery time, improve lung function and oxygenation, and reduce the risk of early relapse, treatment failure, and duration of hospitalization. […] Severe climate events such as extreme heat and wildfire increase likelihood of developing COPD and increase the risk of pneumonia, acute exacerbations, emergency room visits, hospital admissions, ICU admissions requiring ventilation, and death in patients with COPD. […] COPD and Climate Events.
  • #73 Management of chronic obstructive pulmonary disease: A review focusing on exacerbations
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7005599/
    The preference for long-acting muscarinic antagonist (LAMA)/long-acting 2-agonist (LABA) combinations over inhaled corticosteroid (ICS)-containing regimens is supported by evidence from several studies. […] A switch from LABA/ICS to LAMA/LABA is recommended if patients do not respond to ICS or where risks associated with ICS are a concern. […] Short-acting bronchodilators, particularly short-acting 2-agonists, are recommended for treatment of exacerbations and can be combined with short-acting anticholinergics. […] The addition of a systemic corticosteroid to the treatment regimen may be required for moderate-to-severe COPD exacerbations or those that do not respond to short-acting bronchodilators. […] According to Hurst and colleagues, exacerbations in COPD are not random events but occur in a high-risk period for recurrent exacerbation in the 8-week period following an initial exacerbation.
  • #74
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/treatment/
    If you’re still becoming breathless when using a long-acting inhaler, or you have frequent flare-ups (exacerbations), a GP may suggest including a steroid inhaler as part of your treatment. […] If your symptoms are not controlled with inhalers, a doctor may recommend taking tablets or capsules as well. […] If you have a particularly bad flare-up, you may be prescribed a short course of steroid tablets to reduce the inflammation in your airways. […] Pulmonary rehabilitation is a specialised programme of exercise and education designed to help people with lung problems such as COPD. […] Nebulised medicine may be used in severe cases of COPD if inhalers have not worked. […] Roflumilast is a new medicine that can be used to treat flare-ups. […] If COPD causes a low level of oxygen in your blood, you may be advised to have oxygen at home through nasal tubes or a mask. […] Surgery is usually only suitable for a small number of people with severe COPD whose symptoms are not controlled with medicine.
  • #75 Treatment of Stable COPD – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/treatment-of-stable-copd
    All patients with COPD should be given annual influenza vaccinations. […] Patients with COPD are at risk of weight loss and nutritional deficiencies because of a higher energy cost of daily activities, reduced caloric intake relative to need because of dyspnea, and the catabolic effect of inflammatory cytokines such as tumor necrosis factor (TNF)-alpha. […] Pulmonary rehabilitation programs serve as adjuncts to medication treatment to improve physical function. […] Surgical options for treatment of severe COPD include lung volume reduction and lung transplantation. […] Lung volume reduction surgery consists of resecting nonfunctioning emphysematous areas. […] The best candidates for lung volume reduction surgery are patients with an FEV1 20 to 40% of predicted, a diffusing capacity for carbon monoxide (DLCO) 20% of predicted, significantly impaired exercise capacity, heterogeneous pulmonary disease on CT with an upper-lobe predominance, and absence of severe pulmonary hypertension and coronary artery disease. […] Lung transplantation can be single or double.
  • #76 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Surgery is an option for some people with some forms of severe emphysema that aren’t helped enough by medicines alone. Surgical options include lung volume reduction surgery, endoscopic lung volume reduction, lung transplant, and bullectomy. […] For adults with COPD related to AAT deficiency, treatment options include those used for people with more-common types of COPD.
  • #77 Chronic Obstructive Pulmonary Disease: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/0401/p433.html
    Patients with moderate to severe COPD should be evaluated periodically for hypoxemia to determine the need for long-term oxygen therapy. […] Pulmonary rehabilitation consists of structured programs with multidisciplinary health care teams to provide exercise training, education, nutritional counseling, and behavioral modification. […] Although it is expensive and associated with high mortality, lung volume reduction surgery and lung transplantation may be appropriate in select patients, such as those with upper lobe-predominant emphysema or low exercise capacity before treatment. […] The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommends influenza vaccination for persons with COPD, and pneumococcal vaccination for persons 19 to 64 years of age who smoke or have COPD. […] Antitussives, mucolytics, and antibiotics are not currently recommended for long-term treatment of COPD.
  • #78 COPD: Treatment Advances | Montefiore Nyack
    https://www.montefiorenyack.org/health-blog/copd-treatment-advances
    For smokers, a very important part of treatment is smoking cessation. Quitting smoking provides a bigger benefit to people with COPD than anything else, Dr. Krishna said. Treatment can include nicotine replacement therapy and other medications. The FDA recently authorized e-cigarettes, saying the devices could help adults smokers reduce or eliminate their use of cigarettes. […] For patients with severe COPD, a minimally invasive procedure called bronchoscopic lung volume reduction (BLVR) may be recommended. Tiny valves are implanted in the airways of the lungs and act as one-way valves. They block off diseased parts of the lung and allow healthier regions to expand and function more efficiently. The result can be better lung function, easier breathing, improved exercise tolerance and a better quality of life.
  • #79 COPD and Emphysema – Brigham and Women’s Hospital
    https://www.brighamandwomens.org/lung-center/diseases-and-conditions/chronic-obstructive-pulmonary-disease-copd-and-emphysema
    In more severe cases of COPD and emphysema, surgery may be necessary. […] Minimally invasive surgery options include: Lung volume reduction, in which a newer, less-invasive technique using a videoscope (that is, lung volume reduction surgery) or sometimes the endoscope (that is, bronchoscopic lung volume reduction using endobronchial valves) removes or deflates a diseased area of the lung, allowing for the remainder of the lung to expand and improve breathing. […] In the rare situation when COPD and emphysema has severely damaged your lungs, organ transplantation may be necessary. […] COPD and emphysema patients benefit from the wide range of specialists at The Lung Center, including thoracic surgeons, oncologists, pulmonologists, cardiovascular medicine physicians and imaging experts. […] Any surgery recommended will be performed by an experienced, board-certified surgeon, in collaboration with the treatment team including nurses and physician assistants, all of whom specialize in taking care of patients with COPD or emphysema.
  • #80 Treating COPD | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treating
    Pulmonary rehab programs may help improve your lung function, reduce symptoms and the risk of hospital admissions, and improve your quality of life. […] Supplemental oxygen or oxygen therapy increases the amount of oxygen that flows into your lungs. […] Non-invasive ventilation is a form of noninvasive positive pressure ventilation (NPPV) and may decrease mortality and prevent re-hospitalization. […] Endobronchial valve therapy or EBVs are a non-surgical approach for select people living with advanced COPD and emphysema breathe easier. […] In some of these cases, healthcare providers may suggest lung surgery to improve breathing. […] Clinical trials are research studies that test how well new medical approaches work in people. […] Complementary therapies refer to the many therapies, philosophies and practices that are not considered conventional or standard medical care in the United States. […] Palliative care is a specialty in medicine that focuses on relieving the discomfort of symptoms, anxiety, pain and stress that accompany serious illnesses like COPD. […] Advanced directives are medical treatment and care decisions written out ahead of time.
  • #81 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Surgery is an option for some people with some forms of severe emphysema that aren’t helped enough by medicines alone. Surgical options include lung volume reduction surgery, endoscopic lung volume reduction, lung transplant, and bullectomy. […] For adults with COPD related to AAT deficiency, treatment options include those used for people with more-common types of COPD.
  • #82 Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs | Cleveland Clinic Journal of Medicine
    https://www.ccjm.org/content/85/2_suppl_1/s28
    Lung transplantation may be an option for patients with very severe COPD without significant comorbidities. […] The COPD Foundation guidelines provide recommendations for first-and second-line therapy based on diagnosis, and the assessment of severity domains. […] Comorbidities are common among patients with COPD, and COPD itself may increase the risk of developing other diseases. […] Routine follow-up of patients with COPD is essential as lung function may worsen over time, even with the best available care. […] COPD remains underdiagnosed in the United States, with only 50% of individuals with impaired lung function reported to receive a formal diagnosis of COPD. […] Nonpharmacologic therapies such as smoking cessation and pulmonary rehabilitation are recommended at all stages of COPD alongside pharmacologic treatment.
  • #83 Chronic obstructive pulmonary disease (COPD) – Management Approach | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/7/management-approach
    Pulmonary rehabilitation comprises aerobic exercise, strength training, and education. […] GOLD guidelines recommend pulmonary rehabilitation for patients with high symptom burden and risk of exacerbation. […] Extensive pulmonary rehabilitation following hospital admission with an acute exacerbation of COPD decreases the risk of readmission, improves health-related quality of life, and reduces mortality. […] Supplemental oxygen should be titrated to achieve SaO 90%. […] Among different therapeutic modalities in COPD, the only two factors that improve survival are smoking cessation and oxygen supplementation. […] Surgical interventions are the last step in the management of COPD, and include bullectomy, lung volume reduction surgery, and lung transplant. […] Lung transplantation has been shown to improve quality of life and functional capacity. […] Palliative therapies to improve symptoms of dyspnea, offer nutritional support, address anxiety and depression, and reduce fatigue may benefit patients with COPD who experience these despite optimal medical therapy.
  • #84 DUPIXENT® (dupilumab) for Adults with COPD
    https://www.dupixent.com/copd/
    DUPIXENT is an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and a high number of blood eosinophils (a type of white blood cell that may contribute to your COPD). […] WHEN USED WITH COPD INHALERS,* DUPIXENT CAN: Help people breathe easier starting in as little as 2 weeks Help block a key source of inflammation Lead to improvement in patients day-to-day lives Help reduce flare-ups. […] Assessed by SGRQ, a quality of life tool which measures COPD symptoms, physical activity, emotional well-being, and social functioning. In two trials, 51% of patients who received DUPIXENT + SOC experienced a quality of life improvement vs 43% and 47% with placebo + SOC.
  • #85 Promising cure for COPD: is a breakthrough within reach?
    https://www.labiotech.eu/in-depth/copd-cure-breakthrough-treatments/
    Ohtuvayre is a selective dual inhibitor of the phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4) enzymes, combining two properties in one medicine, which ultimately sets it apart in COPD for its ability to both open the airways of patients and reduce inflammation. […] And, just last month, there was another big win for COPD patients, as Regeneron and Sanofi announced that the FDA had expanded the label of their drug Dupixent to treat COPD. […] Although the approvals of Ohtuvayre and Dupixent signify great news for COPD patients, they are not cures for the disease. […] Looking ahead, the researchers are now planning a phase 2 trial of the treatment, which will evaluate its efficacy in a larger group of patients. […] Although COPD does not yet have a cure and there was a long lull in therapeutic advancements until recently, the future now looks promising when it comes to treatment options for the disease.
  • #86 What Is the Latest Treatment for COPD? 8 Treatment Options
    https://www.medicinenet.com/what_is_the_latest_treatment_for_copd/article.htm
    Clinical tests have proven that the lung flute can break up mucus in the lungs, making it effective for diagnostic use and therapy. […] Traditional lung volume reduction surgery (LVRS) involves making a large chest incision to access the lungs to dissect the parts of the lungs that are diseased and dilated. […] During valve surgery, the surgeon uses a bronchoscope to put a one-way valve in the airway. […] Studies have shown a common antibiotic called azithromycin may reduce the number of flare-ups in patients with COPD. […] A new group of biologic drugs called IL-5 antagonists (such as mepolizumab) may work well for COPD patients. […] Treatment for COPD can ease symptoms, prevent complications, and generally slow disease progression. […] These medications help relax the muscles of the airways, widening them so that the patient can breathe easier.
  • #87 What Is the Latest Treatment for COPD? 8 Treatment Options
    https://www.medicinenet.com/what_is_the_latest_treatment_for_copd/article.htm
    Researchers are exploring new treatments for chronic obstructive pulmonary disease (COPD). […] Chronic obstructive pulmonary disease or COPD is a difficult disease to treat with no known cure. However, with recent developments in the medical field, more tools at their disposal, and more knowledge about cellular functions, researchers are exploring new treatment options. […] Bronchial rheoplasty is a new bronchoscopic method for the management of chronic bronchitis. […] TLD is a bronchoscopic intervention designed to disrupt pulmonary nerve reflexes, which may have the potential to reduce COPD exacerbation. […] Stem cells are undifferentiated cells with the ability to become specialized cells. […] This device helps clear excess mucus in the lung and is the only product that uses sound vibration to stimulate the body’s natural mucus-clearing system.
  • #88 What Is the Latest Treatment for COPD? 8 Treatment Options
    https://www.medicinenet.com/what_is_the_latest_treatment_for_copd/article.htm
    Researchers are exploring new treatments for chronic obstructive pulmonary disease (COPD). […] Chronic obstructive pulmonary disease or COPD is a difficult disease to treat with no known cure. However, with recent developments in the medical field, more tools at their disposal, and more knowledge about cellular functions, researchers are exploring new treatment options. […] Bronchial rheoplasty is a new bronchoscopic method for the management of chronic bronchitis. […] TLD is a bronchoscopic intervention designed to disrupt pulmonary nerve reflexes, which may have the potential to reduce COPD exacerbation. […] Stem cells are undifferentiated cells with the ability to become specialized cells. […] This device helps clear excess mucus in the lung and is the only product that uses sound vibration to stimulate the body’s natural mucus-clearing system.
  • #89 Advancements in COPD Treatment: A Promising Cure (2025)
    https://www.dvcstem.com/post/promising-cure-for-copd
    It is important to note that while these advancements contribute to better management of COPD symptoms and improve patients’ quality of life, they do not provide a cure for the disease. […] While these studies show promise in the use of MSCs for COPD treatment, it is important to note that they focus on managing symptoms and improving patients’ quality of life rather than providing a cure for the disease. […] The treatment of COPD aims to relieve symptoms, improve quality of life, prevent disease progression, and reduce exacerbations. […] Current therapies primarily focus on managing symptoms and preventing exacerbations, but they do not offer a complete cure for COPD. […] While current therapies can help stabilize symptoms and slow disease progression, they are often ineffective in halting the progressive decline in lung function that characterizes COPD.
  • #90 Advancements in COPD Treatment: A Promising Cure (2025)
    https://www.dvcstem.com/post/promising-cure-for-copd
    Advancements in COPD treatment have brought about new strategies and technologies that offer hope for improving outcomes in COPD patients. […] Stem cell therapy has emerged as a potential treatment modality for COPD, offering the promise of regenerating damaged lung tissue and restoring lung function. […] Clinical trials are underway to evaluate the safety and efficacy of stem cell therapy for COPD. […] Gene therapy holds promise as a potential treatment approach for COPD. […] Clinical trials are underway to evaluate the safety and efficacy of gene therapy approaches in COPD patients. […] While a complete cure for COPD remains an ambitious goal, recent advancements and ongoing research offer hope for a future where COPD can be effectively managed or even reversed. […] The development of novel therapies, such as stem cell therapy and gene therapy, holds promise for regenerating damaged lung tissue and modulating disease processes at their root. […] Continued research, innovation, and personalized approaches are essential to transforming the landscape of COPD treatment and providing hope for a better future for those affected by this debilitating condition.
  • #91 Chronic Obstructive Pulmonary Disease (COPD) Treatment & Management: Approach Considerations, Smoking Cessation, Management of Inflammation
    https://emedicine.medscape.com/article/297664-treatment
    Long-term oxygen therapy improves survival 2-fold or more in hypoxemic patients with COPD, according to 2 landmark trials, the British Medical Research Council (MRC) study and the US National Heart, Lung and Blood Institutes Nocturnal Oxygen Therapy Trial (NOTT). […] Noninvasive positive-pressure ventilation (NIPPV), as the name suggests, allows the delivery of positive-pressure ventilation without the use of an endotracheal tube. […] Vaccinations are a safe and effective modality to reduce infections in susceptible COPD patients. The pneumococcal vaccine should be offered to all patients older than 65 years or to patients of any age who have an FEV1 of less than 40% of predicted. The influenza vaccine should be given annually to all COPD patients. […] The treatment strategies for AAT deficiency involve reducing the neutrophil elastase burden, primarily by smoking cessation, and augmenting the levels of AAT. Available augmentation strategies include pharmacologic attempts to increase endogenous production of AAT by the liver and administration of purified AAT by periodic intravenous infusion or by inhalation.
  • #92 Chronic Obstructive Pulmonary Disease: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2017/0401/p433.html
    Patients with moderate to severe COPD should be evaluated periodically for hypoxemia to determine the need for long-term oxygen therapy. […] Pulmonary rehabilitation consists of structured programs with multidisciplinary health care teams to provide exercise training, education, nutritional counseling, and behavioral modification. […] Although it is expensive and associated with high mortality, lung volume reduction surgery and lung transplantation may be appropriate in select patients, such as those with upper lobe-predominant emphysema or low exercise capacity before treatment. […] The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommends influenza vaccination for persons with COPD, and pneumococcal vaccination for persons 19 to 64 years of age who smoke or have COPD. […] Antitussives, mucolytics, and antibiotics are not currently recommended for long-term treatment of COPD.
  • #93 COPD: Treatment Advances | Montefiore Nyack
    https://www.montefiorenyack.org/health-blog/copd-treatment-advances
    For a small minority of patients with severe COPD, who are younger than 65 and who require oxygen therapy, the doctor may recommend a lung transplant. […] All COPD patients should be vaccinated for COVID-19, flu, and pneumonia, Dr. Krishna said. A person with COPD is at risk of a worse outcome with all three of these diseases, so its very important they are protected, he said.
  • #94 Chronic Obstructive Pulmonary Disease (COPD) – Pulmonary Disorders – MSD Manual Professional Edition
    https://www.msdmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/chronic-obstructive-pulmonary-disease-copd
    Chronic obstructive pulmonary disease (COPD) is airflow limitation caused by an inflammatory response to inhaled toxins, often cigarette smoke. […] Treatment is with bronchodilators, corticosteroids, and, when necessary, oxygen and antibiotics. […] Smoking cessation is critical in treatment of COPD. […] Treatment of chronic stable COPD aims to prevent exacerbations and improve lung and physical function. […] Treatment relieves symptoms rapidly with primarily short-acting beta-adrenergic medications and decreases exacerbations with inhaled corticosteroids, long-acting beta-adrenergic medications, long-acting anticholinergic medications, or a combination. […] Oxygen therapy is indicated for selected patients. […] Immunization against influenza, pneumococcus, COVID-19, and respiratory syncytial virus (RSV in patients age 60 years and older) should also be recommended as a preventive measure.
  • #95 Chronic Obstructive Pulmonary Disease (COPD)
    https://www.aaaai.org/conditions-treatments/related-conditions/chronic-obstructive-pulmonary-disease-(copd)
    Chronic obstructive pulmonary disease (COPD) is a group of lung diseases (including emphysema and chronic bronchitis) that block airflow in the lungs. This makes it increasingly difficult to breathe. […] Although COPD is one of the leading cause of death and illness worldwide, it is often preventable. […] It is important to distinguish between asthma, COPD or a combination of the two, as the treatment approach will differ. […] There’s no cure for COPD. But proper medications and lifestyle changes can control symptoms and reduce the progression of damage to the lungs. […] If you smoke, stop. It is the only way to prevent COPD from getting worse. […] Medications are used to treat symptoms of COPD. These include: Bronchodilators (beta 2 agonists or anticholinergics) that relax the muscles around the airways Inhaled corticosteroids (in combination with other medications) can be helpful for people with moderate to severe COPD Antibiotics and oral steroids are prescribed during symptom flare-ups because infections can make COPD worse. […] People with COPD are susceptible to getting lung infections, so get flu and pneumonia shots every year. […] Avoid things that can irritate your lungs, such as smoke, pollution, and air that is cold and dry.
  • #96 Chronic Obstructive Pulmonary Disease (COPD) – Treatment : Emergency Care BC
    https://emergencycarebc.ca/clinical_resource/clinical-summary/chronic-obstructive-pulmonary-disease-treatment/
    Chronic Obstructive Pulmonary Disease (COPD) – Treatment […] Acute Exacerbations of COPD (AECOPD) negatively impact health status and disease progression. […] More than 80% of exacerbations are managed on an outpatient basis with pharmacological therapies including bronchodilators, corticosteroids, and antibiotics. […] Oxygen: Titrate oxygen saturation to 88-92%. Avoid overoxygenation. […] Bronchodilators: Short-acting beta2-agonists, with or without short-acting anticholinergics. No difference between both or their combination. No difference in clinical outcomes between inhaled use with a spacer and nebulized administration of these agents. […] Corticosteroids: Improve lung function, oxygenation, risk of early relapse, treatment failure, and the length of hospitalization. Duration: 5-7 days. Oral is equivalent to intravenous. Choice based on patient’s clinical condition. […] Antibiotics: Recommended for patients with: all three cardinal symptoms: increase in dyspnea, sputum volume, and sputum purulence; two cardinal symptoms, if increased purulence of sputum is a symptom; require mechanical ventilation (invasive or noninvasive). Strong benefit among patients admitted to ICU. Duration: 5-7 days. Adjust to local antibiogram. […] Non-Invasive Ventilation (NIV): First-line in patients admitted with acute hypercapnic respiratory failure: Improves gas exchange, work of breathing, mortality and intubation rate. BiPAP is preferred to CPAP. […] Indications for Mechanical Ventilation: NIV contraindication or failure. Respiratory or cardiac arrest. Worsening respiratory fatigue. Decreased level of consciousness. Hemodynamic instability. Persistent hypoxemia. […] Patients treated as outpatients should receive: Education: Inhaler technique. Use of a spacer. Smoking cessation assistance. Vaccinations. Strategies to prevent further exacerbations. […] Medical management: Short-acting inhaled beta-2 agonists, with or without short-acting anticholinergics. Corticosteroid short course. Antibiotics (patients with a change in their sputum). Long-acting inhaled bronchodilators with or without inhaled corticosteroids. […]
  • #97 Management of chronic obstructive pulmonary disease: A review focusing on exacerbations
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7005599/
    Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity and mortality in the United States. Exacerbations acute worsening of COPD symptoms can be mild to severe in nature. Increased healthcare resource use is common among patients with frequent exacerbations, and exacerbations are a major cause of the high 30-day hospital readmission rates associated with COPD. […] Timely and appropriate maintenance pharmacotherapy, particularly dual bronchodilators for maximizing bronchodilation, can significantly reduce exacerbations in patients with COPD. Additionally, multidisciplinary disease-management programs include pulmonary rehabilitation, follow-up appointments, aftercare, inhaler training, and patient education that can reduce hospitalizations and readmissions for patients with COPD.
  • #98 Chronic Obstructive Pulmonary Disease (COPD): Diagnosis and Management – Province of British Columbia
    https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/copd
    Develop an exacerbation action plan with patients. […] Pharmacologic therapies for AECOPD may include: Short-acting bronchodilator for initial treatment of acute exacerbation, Oral corticosteroids for most moderate to severe COPD patients. […] Systemic corticosteroids in AECOPD shorten recovery time, improve lung function and oxygenation, and reduce the risk of early relapse, treatment failure, and duration of hospitalization. […] Severe climate events such as extreme heat and wildfire increase likelihood of developing COPD and increase the risk of pneumonia, acute exacerbations, emergency room visits, hospital admissions, ICU admissions requiring ventilation, and death in patients with COPD. […] COPD and Climate Events.
  • #99 Chronic Obstructive Pulmonary Disease (COPD) | IU Health
    https://iuhealth.org/find-medical-services/chronic-obstructive-pulmonary-disease
    Chronic obstructive pulmonary disease (COPD) consists of lung diseases that keep you from breathing normally, including chronic bronchitis and emphysema. Cigarette smoking most often causes COPD but air pollution and heredity may contribute to its development. […] IU Health Pulmonology & Respiratory Care experts provide leading-edge care while researching new treatments for pulmonary diseases such as COPD. IU Health’s comprehensive system of care employs inpatient and outpatient treatments such as medications, pulmonary rehabilitation and oxygen therapy, tailored to fit your lifestyle. […] IU Health Pulmonology & Respiratory Care physicians offer a full range of treatment options for mild to severe cases of COPD, including: Education. Our specialists provide education on lifestyle changes that reduce the severity of your COPD symptoms, such as eating well and exercising safely.
  • #100 Treatment – Lung Foundation Australia
    https://lungfoundation.com.au/patients-carers/living-with-a-lung-disease/copd/treatment/
    Although there is no current cure for COPD, early treatment is important to help improve how you feel, slow the progression of symptoms, and keep your COPD well managed, including reducing the risk of flare-ups. […] Not all people with COPD have smoked, however, if you do smoke, quitting is the single most important thing you can do to improve your health and lung function. […] COPD research has shown that regular exercise can help maintain your fitness, improve your wellbeing and reduce symptoms, such as breathlessness. […] Pulmonary rehabilitation is an exercise and education program provided by specially trained health professionals. It teaches you the skills needed to exercise safely, manage your breathlessness and to stay well and out of hospital. […] In addition to self-management treatment options, pharmacological (or medicine-based) treatments can also help manage your COPD symptoms.
  • #101 Chronic obstructive pulmonary disease (COPD)
    https://info.health.nz/conditions-treatments/lungs/chronic-obstructive-pulmonary-disease
    Some people in hospital with a severe flare-up of COPD are treated for a short time with breathing support using a mask. […] COPD (chronic obstructive pulmonary disease) can often be managed for many years using modern therapies. […] If you have been diagnosed with COPD, you can stop it getting worse. It will not ever go away completely but there are things you can do to stay well and to make your symptoms less severe. […] This is the best way to reduce your symptoms, and prevent your condition getting worse. […] Keeping active is an important part of helping your breathing. […] If you have developed a plan with your healthcare provider, you can start treating a flare-up at home. […] It is important to have an annual flu vaccine. If you have COPD, you are more likely to be seriously affected by catching the flu or getting a chest infection after the flu. […] Keeping close to a normal weight (not too high, not too low) is good if you have COPD.
  • #102 Treatment of Stable COPD – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/treatment-of-stable-copd
    All patients with COPD should be given annual influenza vaccinations. […] Patients with COPD are at risk of weight loss and nutritional deficiencies because of a higher energy cost of daily activities, reduced caloric intake relative to need because of dyspnea, and the catabolic effect of inflammatory cytokines such as tumor necrosis factor (TNF)-alpha. […] Pulmonary rehabilitation programs serve as adjuncts to medication treatment to improve physical function. […] Surgical options for treatment of severe COPD include lung volume reduction and lung transplantation. […] Lung volume reduction surgery consists of resecting nonfunctioning emphysematous areas. […] The best candidates for lung volume reduction surgery are patients with an FEV1 20 to 40% of predicted, a diffusing capacity for carbon monoxide (DLCO) 20% of predicted, significantly impaired exercise capacity, heterogeneous pulmonary disease on CT with an upper-lobe predominance, and absence of severe pulmonary hypertension and coronary artery disease. […] Lung transplantation can be single or double.
  • #103 Home remedies for COPD: 11 natural treatments
    https://www.medicalnewstoday.com/articles/323649
    COPD can improve with treatment. Home remedies can help relieve coughing, excess mucus production, and other symptoms. […] Although there is currently no cure for COPD, various home remedies can help open up the airways and improve a persons quality of life. […] Quitting smoking is the most effective action that someone who smokes and has COPD can take to slow disease progression. […] A balanced diet can help people with COPD by improving lung function. […] Vitamin D supplements may improve some symptoms of COPD and improve flare-ups. […] Co-enzyme Q10 and creatine are natural chemicals that are involved in supplying energy to the bodys cells. […] Eucalyptus oil has anti-inflammatory properties. […] Myrtol standardized is a safe and effective treatment for both chronic bronchitis and COPD. […] Treating COPD exacerbations early can reduce the likelihood of developing further complications. […] People can reduce their symptoms at home using certain home remedies, including exercises, breathing techniques, dietary supplements, and essential oils.
  • #104 Chronic obstructive pulmonary disease (COPD)
    https://info.health.nz/conditions-treatments/lungs/chronic-obstructive-pulmonary-disease
    Some people in hospital with a severe flare-up of COPD are treated for a short time with breathing support using a mask. […] COPD (chronic obstructive pulmonary disease) can often be managed for many years using modern therapies. […] If you have been diagnosed with COPD, you can stop it getting worse. It will not ever go away completely but there are things you can do to stay well and to make your symptoms less severe. […] This is the best way to reduce your symptoms, and prevent your condition getting worse. […] Keeping active is an important part of helping your breathing. […] If you have developed a plan with your healthcare provider, you can start treating a flare-up at home. […] It is important to have an annual flu vaccine. If you have COPD, you are more likely to be seriously affected by catching the flu or getting a chest infection after the flu. […] Keeping close to a normal weight (not too high, not too low) is good if you have COPD.
  • #105 How COPD Is Treated
    https://www.verywellhealth.com/copd-treatment-915040
    Getting regular exercise is always good for your overall health and wellbeing. For people with COPD, it can help optimize a person’s lung function and increase their lung capacity. […] Breathing exercises can strengthen the diaphragm if you have COPD and improve the exchange of oxygen and carbon dioxide in your body’s cells. […] According to the COPD Foundation, a person with COPD needs anywhere from 430 to 720 extra calories per day to compensate for the extra energy needed for breathing. […] Vaccinations commonly recommended for COPD include pneumococcal pneumonia vaccine and flu vaccination. […] Prescription options include long-acting inhalers that are used on a regular basis to control COPD. Short-acting inhalers are used whenever symptoms flare up. […] Bronchodilators help relax the muscles in the airways. This makes it easier to breathe, reduces coughing, and improves or prevents acute dyspnea (shortness of breath).
  • #106 Chronic Obstructive Pulmonary Disease (COPD) Treatment Options | Temple Health
    https://www.templehealth.org/services/conditions/chronic-obstructive-pulmonary-disease-COPD/treatment-options
    COPD symptoms may make it difficult to eat enough, so your doctor may recommend an eating plan that includes smaller, more frequent meals, eating after resting for a period of time, or vitamins or other nutritional supplements. […] In addition, your doctor might recommend pulmonary rehabilitation, which encompasses a variety of methods designed to improve the well-being of people with chronic breathing problems. […] There are several types of medication that can help to treat COPD: Bronchodilators: relax the muscles around your airways, which helps to open the airways and make breathing easier. […] Inhaled corticosteroid medications: can reduce inflammation of the airways and help prevent exacerbations. […] Oral steroids: short courses of oral corticosteroids are used to treat exacerbations of COPD.
  • #107 How COPD Is Treated
    https://www.verywellhealth.com/copd-treatment-915040
    Getting regular exercise is always good for your overall health and wellbeing. For people with COPD, it can help optimize a person’s lung function and increase their lung capacity. […] Breathing exercises can strengthen the diaphragm if you have COPD and improve the exchange of oxygen and carbon dioxide in your body’s cells. […] According to the COPD Foundation, a person with COPD needs anywhere from 430 to 720 extra calories per day to compensate for the extra energy needed for breathing. […] Vaccinations commonly recommended for COPD include pneumococcal pneumonia vaccine and flu vaccination. […] Prescription options include long-acting inhalers that are used on a regular basis to control COPD. Short-acting inhalers are used whenever symptoms flare up. […] Bronchodilators help relax the muscles in the airways. This makes it easier to breathe, reduces coughing, and improves or prevents acute dyspnea (shortness of breath).
  • #108 Patient education: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-copd-treatments-beyond-the-basics
    Preventing and treating infections — Getting sick with a respiratory infection can lead to COPD exacerbations. […] Nutrition — Some people with advanced COPD are not able to eat enough because of their symptoms. […] Regular monitoring — Seeing your health care provider regularly is an important part of managing your COPD. […] The best approach to treatment (including what medications your health care provider will prescribe) will depend, in part, on how severe your COPD is. […] In addition to the measures discussed above, the treatment of COPD involves medication therapy. […] Bronchodilators — Medications that help open the airways, called bronchodilators, are a mainstay of treatment for COPD. […] Glucocorticoids — Glucocorticoids are a class of medication that has anti-inflammatory properties.
  • #109 Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs | Cleveland Clinic Journal of Medicine
    https://www.ccjm.org/content/85/2_suppl_1/s28
    Lung transplantation may be an option for patients with very severe COPD without significant comorbidities. […] The COPD Foundation guidelines provide recommendations for first-and second-line therapy based on diagnosis, and the assessment of severity domains. […] Comorbidities are common among patients with COPD, and COPD itself may increase the risk of developing other diseases. […] Routine follow-up of patients with COPD is essential as lung function may worsen over time, even with the best available care. […] COPD remains underdiagnosed in the United States, with only 50% of individuals with impaired lung function reported to receive a formal diagnosis of COPD. […] Nonpharmacologic therapies such as smoking cessation and pulmonary rehabilitation are recommended at all stages of COPD alongside pharmacologic treatment.
  • #110 Improving the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) – www.westernhealth.com
    https://www.westernhealth.com/provider/quality-and-safety/secure/hedis-performance-measurement/chronic-obstructive-pulmonary-disease-copd/
    According to the National Heart, Lung, and Blood Institute (NHLBI), COPD is leading cause of both disability and death in the United States. As of 2018 16.4 million Americans have been diagnosed with COPD, along with millions more who may have the disease without even knowing they have it. […] COPD includes chronic bronchitis and emphysema, and is characterized by chronic airflow limitation that is not fully reversible, is usually progressive, and is associated with an abnormal inflammatory response. Spirometry testing is required to make the diagnosis of COPD, assess airflow limitation, and help in determining the severity of the disease. It can be used to monitor specific treatment steps, as well as the progression of the disease (Global Initiative for Chronic Obstructive Lung Disease; GOLD 2019).
  • #111 GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and | COPD
    https://www.dovepress.com/gold-in-practice-chronic-obstructive-pulmonary-disease-treatment-and-m-peer-reviewed-fulltext-article-COPD
    Bronchodilators—the first-choice pharmacotherapy for COPD across all patient groups—increase airway diameter and decrease air trapping, thereby improving airflow and reducing dyspnea. […] For patients with persistent breathlessness or exercise limitation despite long-acting bronchodilator monotherapy, step-up to a LAMA+LABA is recommended. […] Pharmacological therapy for COPD should be complemented with nonpharmacological approaches, including behavioral therapies and pulmonary rehabilitation, as appropriate. […] Chronic disease management involves regular evaluation to monitor disease progression and treatment response. […] Ensuring continuity of care over time is central to chronic disease management programs, including those for COPD. […] COPD is a leading cause of morbidity and mortality in the United States. Because most patients with COPD are managed in the primary care setting, primary care clinicians play a pivotal role in appropriately managing COPD.
  • #112 Chronic Obstructive Pulmonary Disease (COPD): Diagnosis and Management – Province of British Columbia
    https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/copd
    Non-pharmacological therapy is complementary and part of a comprehensive approach to managing COPD. […] All patients who smoke and have COPD should be encouraged to quit, as treatment for COPD. […] When prescribing medication for patients with COPD: Choose medications based on severity. […] Evaluate the patient’s adherence and inhaler technique regularly, as up to 50% of patients use their device incorrectly. […] An ICS is typically added to a medication regimen last, due to an increased risk of pneumonia. […] The use of blood eosinophil counts to help guide therapy with ICS for patients with exacerbations is an emerging practice. […] A high eosinophil count (0.3 x 109/L) indicates a patient will likely respond well to ICS treatment, resulting in fewer acute exacerbations. […] More than 80% of exacerbations can be managed on an outpatient basis with pharmacologic therapies.
  • #113 Chronic obstructive pulmonary disease (COPD) – Management Approach | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/7/management-approach
    Ongoing monitoring and assessment in COPD ensures that the goals of treatment are being met. Quality of life and patients’ sense of wellbeing will improve, and hospital admissions will be significantly decreased, when self- or professional monitoring of disease is being utilized. […] One Cochrane review found that integrated disease management (IDM), in which several healthcare providers (physical therapist, pulmonologist, nurse, etc.) work together with patients, probably results in improvement in disease-specific quality of life, exercise capacity, hospital admissions, and hospital days per person. […] The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend that initial treatment is determined by the patients GOLD group at diagnosis. […] Rescue short-acting bronchodilators should be prescribed to all patients for immediate symptom relief.
  • #114 Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs | Cleveland Clinic Journal of Medicine
    https://www.ccjm.org/content/85/2_suppl_1/s28
    Chronic obstructive pulmonary disease (COPD) is common, often seen in primary care daily practice, and places a substantial burden on patients, their families, and society. […] Both pharmacologic and nonpharmacologic treatment options can reduce symptoms, treat comorbidities, prevent exacerbation, and improve quality of life, exercise tolerance, and health status in patients with COPD. […] Primary care physicians manage the care of approximately 80% of patients with COPD. […] Both the Global Initiative for Obstructive Lung Disease (GOLD) and COPD Foundation guidelines recommend individualized care for patients with COPD. […] Smoking cessation and pulmonary rehabilitation are central to effective COPD disease management. […] Pulmonary rehabilitation is recommended for any COPD patient of GOLD grades B-D.
  • #115 Get Chronic Obstructive Pulmonary Disease (COPD) Care | Cleveland Clinic
    https://my.clevelandclinic.org/services/copd-treatment
    COPD is a chronic (lifelong) condition. But we can slow it down with the right treatment, helping you feel your best and stay independent and active. Our providers will support you with personalized therapies and rehabilitation to reduce your COPD symptoms. […] Smoking causes about 90% of COPD cases. So kicking a smoking habit (if you have one) is the best thing you can do to slow down COPD. We’ll give you the tools and support you need to become and stay smoke-free. […] Your provider may prescribe medication for your COPD symptoms. Medications could include a combination of bronchodilators and steroids to open your airways and reduce inflammation. Sometimes, biological treatments, phosphodiesterase inhibitors and long-term, low-dose macrolide therapy may also improve your symptoms and quality of life.
  • #116 GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and | COPD
    https://www.dovepress.com/gold-in-practice-chronic-obstructive-pulmonary-disease-treatment-and-m-peer-reviewed-fulltext-article-COPD
    Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality. Early detection and appropriate treatment and management of COPD can lower morbidity and perhaps mortality. […] In this review, we provide an overview of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 report, with a focus on the management of COPD in the primary care setting. […] The Global Initiative for Chronic Obstructive Lung Disease (GOLD) report includes recommended strategies for the diagnosis, treatment, and management of COPD. […] After categorizing a patient as belonging to GOLD group A, B, C, or D, the GOLD treatment algorithm can be used to determine appropriate initial pharmacological treatment, which should be complemented with nonpharmacological approaches as appropriate.
  • #117 Chronic obstructive pulmonary disease (COPD) – Management Approach | BMJ Best Practice US
    https://bestpractice.bmj.com/topics/en-us/7/management-approach
    For group A patients (few symptoms and low risk of exacerbations), a short-acting or a long-acting bronchodilator is offered first-line. […] For group B patients (more symptoms and low risk of exacerbations), LABA/LAMA combination treatment should be offered first-line in the absence of issues with adverse effects or availability. […] For group E patients (high risk of exacerbations and any level of symptoms), LABA/LAMA combination treatment is first-line therapy in the absence of issues with adverse effects or availability. […] Further treatment is determined by the patient’s dyspnea/exercise limitation symptom burden and frequency of exacerbations after review and is independent of the patient’s GOLD group at diagnosis. […] Recommended escalation therapy for patients with persistent dyspnea/exercise limitation after initial therapy is as follows: Patients taking long-acting bronchodilator monotherapy should start a second long-acting bronchodilator.
  • #118 Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs | Cleveland Clinic Journal of Medicine
    https://www.ccjm.org/content/85/2_suppl_1/s28
    Lung transplantation may be an option for patients with very severe COPD without significant comorbidities. […] The COPD Foundation guidelines provide recommendations for first-and second-line therapy based on diagnosis, and the assessment of severity domains. […] Comorbidities are common among patients with COPD, and COPD itself may increase the risk of developing other diseases. […] Routine follow-up of patients with COPD is essential as lung function may worsen over time, even with the best available care. […] COPD remains underdiagnosed in the United States, with only 50% of individuals with impaired lung function reported to receive a formal diagnosis of COPD. […] Nonpharmacologic therapies such as smoking cessation and pulmonary rehabilitation are recommended at all stages of COPD alongside pharmacologic treatment.
  • #119 COPD Diagnosis and Treatment – Atlantic Health
    https://ahs.atlantichealth.org/conditions-treatments/pulmonary-services/chronic-obstructive-pulmonary-disease.html
    Co-existing medical conditions, such as depression, heart disease, lung cancer, osteoporosis and sleep apnea, are common in patients with COPD and require additional attention to manage symptoms. […] Atlantic Home Care provides COPD management services in the comfort of patients homes, so they can prevent or postpone hospitalizations. The programs home health aides use TeleHealth technology to monitor each patient’s status on a daily basis and based on results, will recommend medications, exercises or lifestyle changes to minimize COPD symptoms.
  • #120
    https://www.nhs.uk/conditions/chronic-obstructive-pulmonary-disease-copd/
    Chronic obstructive pulmonary disease (COPD) is the name for a group of lung conditions that cause breathing difficulties. […] The breathing problems tend to get gradually worse over time and can limit your normal activities, although treatment can help keep the condition under control. […] Do not ignore the symptoms. If they’re caused by COPD, it’s best to start treatment as soon as possible, before your lungs become significantly damaged. […] The damage to the lungs caused by COPD is permanent, but treatment can help slow down the progression of the condition. […] Treatments include: stopping smoking if you have COPD and you smoke, this is the most important thing you can do; inhalers and medicines to help make breathing easier; pulmonary rehabilitation a specialised programme of exercise and education; surgery or a lung transplant although this is only an option for a very small number of people. […] The outlook for COPD varies from person to person. The condition cannot be cured or reversed, but for many people, treatment can help keep it under control so it does not severely limit their daily activities.
  • #121 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Treatment is based on how severe your symptoms are and whether you often have bouts when symptoms get worse. These bouts are called exacerbations. Effective therapy can control symptoms, slow how fast the condition worsens, lower the risk of complications and improve your ability to lead an active life. […] The most essential step in any treatment plan for COPD is to quit all smoking. Stopping smoking can keep COPD from getting worse and making it harder to breathe. […] Several kinds of medicines are used to treat the symptoms and complications of COPD. You may take some medicines on a regular basis and others as needed. […] Most medicines for COPD are given using an inhaler. This small hand-held device delivers the medicine straight to your lungs when you breathe in the fine mist or powder.
  • #122 COPD – Treatment | NHLBI, NIH
    https://www.nhlbi.nih.gov/health/copd/treatment
    If you are diagnosed with COPD, your healthcare provider will determine your treatment plan based on your symptoms and whether you have mild or severe COPD. […] Medicines to treat COPD symptoms include bronchodilators and steroids or nonsteroid medicines that reduce inflammation. A new add-on medicine approved in 2024 may help to control your disease. Your healthcare provider may prescribe an inhaler for you to always carry. Inhalers allow the medicine to go straight to your lungs. […] If your COPD is mild and you dont have symptoms often, your provider may prescribe a short-acting bronchodilator that you take only when you have symptoms. Bronchodilators relax the muscles around your airways, opening them up to help make breathing easier. Short-acting bronchodilators last about 4 to 6 hours.
  • #123 COPD – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/copd/diagnosis-treatment/drc-20353685
    Bronchodilators are medicines that usually come in inhalers. Bronchodilators relax the muscles around the airways. This can help relieve coughing and make breathing easier. […] Inhaled corticosteroids, often simply called steroids, can lessen airway inflammation and help prevent bouts when COPD symptoms get worse. […] For times when COPD symptoms get worse, short courses of oral corticosteroids for example, 3 to 5 days may prevent more worsening of COPD. […] A medicine approved for severe COPD and symptoms of chronic bronchitis is roflumilast (Daliresp), a phosphodiesterase-4 inhibitor. This medicine lessens airway inflammation and relaxes the airways. […] Oxygen therapy, a pulmonary rehabilitation program and in-home noninvasive ventilation therapy can all help treat COPD. […] These programs usually combine health education, exercise training, breathing techniques, nutrition advice and counseling.
  • #124 Treatment of Stable COPD – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/treatment-of-stable-copd
    The frequency of exacerbations can be reduced with the use of anticholinergics, inhaled corticosteroids, or long-acting beta-agonists. […] For home treatment of chronic stable disease, medication administration by metered-dose inhaler or dry-powder inhaler is preferred over administration by nebulizer. […] Inhaled corticosteroids seem to reduce airway inflammation, reverse beta-receptor down-regulation, and inhibit leukotriene and cytokine production. […] They are indicated for patients who have repeated exacerbations or symptoms despite optimal bronchodilator therapy. […] Long-term oxygen therapy prolongs life in patients with COPD whose partial pressure of arterial oxygen (PaO2) is chronically 55 mm Hg. […] Oxygen therapy does the following: brings hematocrit toward normal levels, improves neuropsychologic factors, ameliorates pulmonary hemodynamic abnormalities, and increases exercise tolerance in some patients.
  • #125 Chronic Obstructive Pulmonary Disease (COPD) Treatment & Management: Approach Considerations, Smoking Cessation, Management of Inflammation
    https://emedicine.medscape.com/article/297664-treatment
    Long-term oxygen therapy improves survival 2-fold or more in hypoxemic patients with COPD, according to 2 landmark trials, the British Medical Research Council (MRC) study and the US National Heart, Lung and Blood Institutes Nocturnal Oxygen Therapy Trial (NOTT). […] Noninvasive positive-pressure ventilation (NIPPV), as the name suggests, allows the delivery of positive-pressure ventilation without the use of an endotracheal tube. […] Vaccinations are a safe and effective modality to reduce infections in susceptible COPD patients. The pneumococcal vaccine should be offered to all patients older than 65 years or to patients of any age who have an FEV1 of less than 40% of predicted. The influenza vaccine should be given annually to all COPD patients. […] The treatment strategies for AAT deficiency involve reducing the neutrophil elastase burden, primarily by smoking cessation, and augmenting the levels of AAT. Available augmentation strategies include pharmacologic attempts to increase endogenous production of AAT by the liver and administration of purified AAT by periodic intravenous infusion or by inhalation.
  • #126 Management of chronic obstructive pulmonary disease: A review focusing on exacerbations
    https://pmc.ncbi.nlm.nih.gov/articles/PMC7005599/
    Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity and mortality in the United States. Exacerbations acute worsening of COPD symptoms can be mild to severe in nature. Increased healthcare resource use is common among patients with frequent exacerbations, and exacerbations are a major cause of the high 30-day hospital readmission rates associated with COPD. […] Timely and appropriate maintenance pharmacotherapy, particularly dual bronchodilators for maximizing bronchodilation, can significantly reduce exacerbations in patients with COPD. Additionally, multidisciplinary disease-management programs include pulmonary rehabilitation, follow-up appointments, aftercare, inhaler training, and patient education that can reduce hospitalizations and readmissions for patients with COPD.
  • #127 Patient education: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-copd-treatments-beyond-the-basics
    Preventing and treating infections — Getting sick with a respiratory infection can lead to COPD exacerbations. […] Nutrition — Some people with advanced COPD are not able to eat enough because of their symptoms. […] Regular monitoring — Seeing your health care provider regularly is an important part of managing your COPD. […] The best approach to treatment (including what medications your health care provider will prescribe) will depend, in part, on how severe your COPD is. […] In addition to the measures discussed above, the treatment of COPD involves medication therapy. […] Bronchodilators — Medications that help open the airways, called bronchodilators, are a mainstay of treatment for COPD. […] Glucocorticoids — Glucocorticoids are a class of medication that has anti-inflammatory properties.
  • #128 Promising cure for COPD: is a breakthrough within reach?
    https://www.labiotech.eu/in-depth/copd-cure-breakthrough-treatments/
    Ultimately, the recent approvals of Ohtuvayre and Dupixent as well as the promise of the treatments currently in development mean that the quality of life and overall health of people living with COPD are constantly being improved. And, with more research being invested in regenerative medicine, a promising cure for COPD may well be on the horizon, too.